Publications 2002 - 2008

DWYER

1. Steain MC, Wang B, Dwyer DE, Saksena NK.
   
   HIV-1 coinfection, superinfection and recombination.
   
   Sexual Health 2004; 1:239-250.
2. He ZP, Dong Q, Zhuang H, Song S, Peng G, Luo G, Dwyer DE.
   
   Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.
   
   International Journal of Infectious Diseases 2005; 9:323-330.
3. Young LC, Dwyer DE, Harris M, Guse Z, Noel V, Levy MH on behalf of the Prison Influenza Outbreak Investigation Team.
   
   Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus.
   
   Epidemiology and Infection 2005; 133:107-112.
4. Chew CB, Potter SJ, Wang B, Wang YM, Shaw CO, Dwyer DE, Saksena NK.
   
   Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
   
   Journal of Clinical Virology 2005; 33:206-216.
5. Telfer BL, Moberly SA, Hort KP, Branley JM, Dwyer DE, Muscatello DJ, Corell PK, McAnulty JM.
   
   A community wide outbreak of psittacosis linked to wild birds.
   
   Emerging Infectious Diseases 2005; 11:391-397.
6. Wang B, Potter SJ, Lin Y, Cunningham AL, Dwyer DE, Su Y, Hou Y, Saksena NK.
   
   Rapid and sensitive detection of Severe Acute Respiratory Syndrome coronavirus by rolling circle amplification.
   
   Journal of Clinical Microbiology 2005; 43:2339-2344.
7. Robertson AG, Dwyer DE, Leclerq MG.
   
   “Operation South East Asia Tsunami Assist”: an Australian team in the Maldives.
   
   Medical Journal of Australia 2005; 182:340-342.
8. Winston A, Hales G, Amin J, van Schaick E, Cooper DA, Emery S on behalf of the CREST Investigators.
   
   The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1 infected individuals.
   
   AIDS 2005; 19:1393-1399.
9. Potter SJ, Lemey P, Dyer WB, Sullivan JS, Chew CB, Vandamme A-M, Dwyer DE, Saksena NK.
   
   Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART.
   
   Virology 2006; 348:35-46.
10. Sanders SA, Herrero LJ, McPhie K, Chow SSW, Craig ME, Dwyer DE, Rawlinson W, McMinn PC.
    
    Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community.
    
    Archives of Virology 2006; 151:1003-1013.
11. Spruance SL, Bodsworth N, Resnick H, Conant M, Oeuvray C, Gao J, Hamed K.
    
    The Famvir Study Group. Single-dose, patient-initiated famciclovir: A randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
    
    Journal of the American Academy of Dermatology 2006; 55:47-53.
12. Dwyer DE, McPhie KA, Ratnamohan VM, Pitman CNM.
    
    Challenges for the laboratory before and during an influenza pandemic.
    
    NSW Public Health Bulletin 2006; 17:141-144.
13. Haddow L, Dave B, Mindel A, Chung C, Marks C, Dwyer DE.
    
    Increase in rates of herpes simplex type 1 as a cause of anogenital herpes in western Sydney, Australia between 1979 and 2003.
    
    Sexually Transmitted Infections 2006; 82:255-259.
14. Hales G, Birch C, Crowe S, Workman C, Hoy JA, Law MG, Kelleher AD, Lincoln D, Emery S on behalf of the CREST Investigators.
    
    A randomised trial comparing genotypic and virtual interpretation of HIV drug resistance: The CREST study.
    
    Public Library of Science (PLoS) Clinical Trials 2006; 1(3):e18. DOI:10.1371/journal.pctr.0010018.
15. Weston KM, Dwyer DE, Ratnamohan M, McPhie K, Chan SW, Branley JM, Allchin LJ, Hort KP.
    
    Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal.
    
    Communicable Diseases Intelligence 2006; 30:358-365.
16. Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert GL.
    
    Seroepidemiology of cytomegalovirus infection in Australia.
    
    Clinical and Vaccine Immunology 2006; 13:1181-1184.
17. INITIO Trial International Co-ordinating Committee.
    
    Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label, randomised trial.
    
    Lancet 2006; 368:287-298.
18. Dwyer DE, Workman C, Hales G, Amin J, Cooper D, John Miller J, Emery S on behalf of the ALLIANCE Study Group.
    
    Enfuvirtide in HIV-1 infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study.
    
    Antiviral Therapy 2006; 11:409-419.
19. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group.
    
    CD4+ count-guided interruption of antiretroviral treatment.
    
    New England Journal of Medicine 2006; 355:2283-2296.
20. Dwyer DE, Smith DW, Catton MG, Barr IG.
    
    Laboratory diagnosis of human seasonal and pandemic influenza virus infection.
    
    Medical Journal of Australia 2006; 185:S48-S53.
21. Harrod ME, Emery S, Dwyer DE.
    
    Antivirals in the management of an influenza pandemic.
    
    Medical Journal of Australia 2006; 185:S58-S61.
22. He ZP, Zhuang H, Zhao C, Dong Q, Peng G, Dwyer DE.
    
    Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV).
    
    Virology Journal 2007; 4:32 doi:10.1186/1743-422X-4-32.
23. Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; on behalf of the INITIO Trial International Coordinating Committee.
    
    Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.
    
    AIDS 2007; 21:2445-2453.
24. Seale H, MacIntyre CR, Dwyer DE, Wang H.
    
    The changing epidemiology of severe cytomegalovirus disease in Australia.
    
    Human Vaccines 2007; 6:239-244.
25. Wang B, Lau KA, Ong L-Y, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK.
    
    Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants.
    
    Virology 2007; 367:288-297.
26. Swaminathan A, Martin R, Gamon S, Aboltins C, Athan E, Braitberg G, Catton M, Cooley L, Dwyer DE, Edmonds D, Eisen D, Hosking K, Hughes A, Johnson PDR, McLeod A, O’Reilly M, Peters E, Stuart RL, Moran R, Grayson ML.
    
    Quantifying personal protective equipment (PPE) and antiviral use during the initial acute management of suspected human cases of pandemic influenza.
    
    Emerging Infectious Diseases 2007; 13:1541-1547.
27. Verity EE, Zotos D, Wilson K, Chatfield C, Lawson VA, Dwyer DE, Cunningham A, Learmont J, Dyer W, Sullivan J, Churchill M, Wesselingh SL, Gabuzda D, Gorry PR, McPhee DA.
    
    Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat region.
    
    Journal of Virology 2007; 81: 9268-9278.
28. Bucciardini R, Fragola V, Massella M, Polizzi C, Mirra M, Goodall R, Carey D, Hudson F, Zajdenverg R, Floridia M on behalf of the INITIO Trial International Coordinating Committee.
    
    Health-Related Quality of Life Outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: The INITIO-QoL Substudy.
    
    AIDS Research and Human Retroviruses 2007; 23:1215-22.
29. Dwyer DE, Sintchenko V.
    
    Point-of-care testing for community-acquired pneumonia: Do we have all the answers?
    
    Medical Journal of Australia 2007; 187:40-42.
30. Vinney KA, Kehoe PJ, Doyle B, Sheppeard V, Roberts-Witteveen AR, Semirli H, McPhie K, Dwyer DE, McAnulty JM.
    
    An outbreak of epidemic keratoconjunctivitis in a regional opthalmology clinic in New South Wales.
    
    Epidemiology and Infection 2007 Nov 30;:1-10: doi: 10.1017/S0950268807009843.
31. Wu JQ, Wang B, Belov L, Chrisp J, Learmont J, Dyer WB, Zaunders J, Cunningham AL, Dwyer DE, Saksena NK.
    
    Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.
    
    Retrovirology. 2007; 4:83; doi:10.1186/1742-4690-4-83.
32. Carey DL, Baker D, Rogers GD, Petoumenos K, Chuah J, Easey N, Machon K, Cooper DA, Emery S, Carr A for the Facial LipoAtrophy Study in HIV (FLASH) Investigators.
    
    A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy.
    
    Journal of the Acquired Immune Deficiency Syndrome 2007; 46:581-589.
33. Ho YS, Abecasis AB, Theys K, Deforche K, Dwyer DE, Charleston M, Vandamme AM, Saksena NK.
    
    HIV-1 gp120 N-Linked glycosylation differs between plasma and leukocyte compartments.
    
    Virology Journal 2008, 5:14; doi:10.1186/1743-422X-5-14.
34. Zhou L, Ng T, Yuksel A, Wang B, Dwyer DE, Saksena NK.
    
    Absence of HIV infection in the choroid plexus of two patients who died rapidly with HIV-associated dementia.
    
    AIDS Research and Human Retroviruses 2008; 24:839-843.
35. Branley J, Roy B, Dwyer DE, Sorrell TC.
    
    Real-time PCR detection and quantitation of Chlamydophilia psittaci in human and avian specimens from a veterinary clinic cluster.
    
    European Journal of Clinical Microbiology and Infectious Diseases 2008; 27:269-273.
36. Dwyer DE.
    
    Seasonal, avian and pandemic influenza viruses.
    
    Australian Defence Forces Health 2008; 9:2-7.
37. Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, Levin MJ, MacIntyre CR.
    
    The prevention and management of herpes zoster.
    
    Medical Journal of Australia 2008; 188:171-176.
38. Boyd MA, Truman M, Hales G, Anderson J, Dwyer DE, Carr A.
    
    A randomized study to evaluate injection site reactions using three different mechanisms for delivery of enfuvirtide: a 27-gauge needle, a 31-gauge needle and a needle-free device (The OPTIONS Study).
    
    Antiviral Therapy 2008; 13:449-453.
39. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R.
    
    Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
    
    Journal of Infectious Diseases 2008; 197:1133-1144.
40. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN.
    
    Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
    
    Journal of Infectious Diseases 2008; 197:1145-1155.
41. Toi CS, Dwyer DE.
    
    Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high resolution melt analysis of single nucleotide polymorphisms.
    
    Journal of Clinical Virology 2008; 43:18-24.
42. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK.
    
    Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses.
    
    Virology 2008 (on line 09/08/2008).
43. Seale H, Dwyer DE, Chapman JR, MacIntyre CR.
    
    Cytomegalovirus disease amongst renal transplant recipients in Australia and New Zealand.
    
    Virology: Research and Treatment (on line 01/09/08)

Book Chapters

1. Pitman C, Dwyer DE.
   
   Laboratory testing for antiviral drug resistance.
   
   In “Antimicrobial Susceptibility Testing: Methods and Practices with an Australian Perspective”. Editor Merlino J. ASM Manual 2004.
2. Crowe SM, Dwyer DE, Cunningham AL, Mills J.
   
   Antiviral Agents. Chapter 45, pp540-550.
   
   In “Infectious Diseases: A Clinical Approach”, 2nd Edition. Editors: Yung A, McDonald M, Spelman D, Street A, Johnson P, Sorrell T, McCormack J. IP Communications, Victoria 2005.
3. Wesselingh S, Dwyer DE.
   
   Influenza. Chapter 26, pp310-315.
   
   In “Infectious Diseases: A Clinical Approach”, 2nd Edition. Editors: Yung A, McDonald M, Spelman D, Street A, Johnson P, Sorrell T, McCormack J. IP Communications, Victoria 2005.
4. Cunningham AL, Mindel A, Dwyer DE.
   
   “Clinician’s Manual on Genital Herpes”.
   
   Current Medicine Group Ltd, London 2007 (Third edition).
5. van Hal SJ, Dwyer DE.
   
   Herpes simplex: virus and infection.
   
   Encyclopaedia of Life Sciences. John Wiley and Sons, Ltd, Chichester, United Kingdom 2008.

GILBERT

1. Brotherton JM, Delpech VC, Gilbert GL, Hatzi S, Paraskevopoulos PD, McAnulty JM, et al.
   
   A large outbreak of influenza A and B on a cruise ship causing widespread morbidity.
   
   Epidemiology & Infection 2003;130(2):263-71. (IF 1.809) (11 citations)
2. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL.
   
   The seroepidemiology and transmission dynamics of varicella in Australia.
   
   Epidemiology & Infection 2003;131(3):1085-9. (IF 1.809) (15 citations)
3. Gilbert GL, Hewitt MC, Turner CM, Leeder SR.
   
   Compliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations.
   
   Infectious Diseases in Obstetrics & Gynecology 2003;11(1):1-9.
4. James G, Yuen M, Gilbert L.
   
   Laboratory investigation of suspected bioterrorism incidents, New South Wales, October 2001 to February 2002.
   
   New South Wales Public Health Bulletin 2003;14(11-12):221-3.
5. Kong F, Gilbert GL.
   
   Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes.
   
   Journal of Medical Microbiology 2003;52(12):1047-58. (IF 2.442)
6. Kong F, Martin D, James G, Gilbert GL.
   
   Towards a genotyping system for Streptococcus agalactiae (group B streptococcus): use of mobile genetic elements in Australasian invasive isolates.
   
   Journal of Medical Microbiology 2003;52(Pt 4):337-44. (IF 2.442) (12 citations)
7. Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, et al.
   
   Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
   
   Communicable Diseases Intelligence 2003;27(4):478-87.
8. Amin J, Gidding H, Gilbert G, Backhouse J, Kaldor J, Dore G, et al.
   
   Hepatitis C prevalence--a nationwide serosurvey.
   
   Communicable Diseases Intelligence 2004;28(4):517-21.
9. Kong F, Gilbert GL.
   
   Postgenomic taxonomy of human ureaplasmas - a case study based on multiple gene sequences.
   
   International Journal of Systematic & Evolutionary Microbiology 2004;54(Pt 5):1815-21.(IF 2.662)
10. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL,
    
    Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000.
    
    Australian & New Zealand Journal of Public Health 2004;28(3):212-6.(19 citations)
11. Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL.
    
    Temporal trends in circulating Bordetella pertussis strains in Australia.
    
    Epidemiology & Infection 2004;132(2):185-93. (IF 1.809) (13 citations)
12. Raynes-Greenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL.
    
    Antibiotics for ureaplasma in the vagina in pregnancy.
    
    Cochrane Database of Systematic Reviews 2004;1.
13. Sintchenko V, Coiera E, Iredell JR, Gilbert GL.
    
    Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases.
    
    Journal of the American Medical Informatics Association 2004;11(1):71-7. (11 citations)
14. Wang H, Kong F, Jelfs P, James G, Gilbert GL.
    
    Simultaneous detection and identification of common cell culture contaminant and pathogenic mollicutes strains by reverse line blot hybridization.
    
    Applied & Environmental Microbiology 2004;70(3):1483-6. (IF 3.532)
15. Watson M, Roche P, Bayley K, Bell JM, Collignon P, Gilbert GL, et al.
    
    Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    
    Communicable Diseases Intelligence 2004;28(4):455-64.
16. Gidding HF, Backhouse JL, Gilbert GL, Burgess MA.
    
    National serosurvey of poliovirus immunity in Australia, 1996-99.
    
    Australian & New Zealand Journal of Public Health 2005;29(1):48-52.
17. Gidding HF, Backhouse JL, Burgess MA, Gilbert GL.
    
    Immunity to diphtheria and tetanus in Australia: a national serosurvey.
    
    Medical Journal of Australia 2005;183(6):301-4.
18. Horby P, Macintyre CR, McIntyre PB, Gilbert GL, Staff M, Hanlon M, et al.
    
    A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods.
    
    Epidemiology & Infection 2005;133(2):229-36. (IF 1.809)
19. Kong F, Wang W, Tao J, Wang L, Wang Q, Sabananthan A, Gilbert GL.
    
    A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR.
    
    Journal of Medical Microbiology 2005;54(4):351-6. (IF 2.318)_
20. Kong F, Ma L, Gilbert GL.
    
    Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization.
    
    Journal of Medical Microbiology 2005;54(Pt 12):1133-8. (IF 2.318)
21. Sintchenko V, Iredell JR, Gilbert GL,
    
    Coiera E. Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.
    
    Journal of the American Medical Informatics Association 2005;12(4):398-402. (18 citations)
22. Sun Y, Kong F, Zhao Z, Gilbert GL.
    
    Comparison of a 3-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (group B streptococcus).
    
    Journal of Clinical Microbiology 2005;43(9):4704-47. (IF 3.445)
23. Wood N, Backhouse J, Gidding HF, Gilbert GL, Lum G, McIntyre PB.
    
    Estimates of chronic hepatitis B virus infection in the Northern Territory.
    
    Communicable Diseases Intelligence 2005;29(3):289-90.
24. Britton W J, Gilbert G L, Wheatley J, Leslie D, Rothel J S, Jones S L, Bradley P.
    
    Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Mycobacterium tuberculosis in patients with culture positive tuberculosis.
    
    Tuberculosis 2005; 85(3):137-45
25. Backhouse JL, Gidding HF, McIntyre PB, Gilbert GL.
    
    Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus.
    
    Clinical & Vaccine Immunology: CVI 2006;13(7):764-7.
26. Ip M, Cheuk ES, Tsui MH, Kong F, Leung TN, Gilbert GL.
    
    Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong.
    
    Journal of Clinical Microbiology 2006;44(11):4252-4. (IF 3.445)
27. Kong F, Gilbert GL.
    
    Multiplex PCR-based reverse line blot hybridization assay (mPCR-RLB) - a practical epidemiological and diagnostic tool.
    
    Nature Protocols 2006;1: 2668-2680 (invited paper, based on several previous papers describing the use of a novel method)
28. Jelfs P, Sintchenko V, Gilbert GL.
    
    Genotyping of Mycobacterium tuberculosis in New South Wales: results from 18 months of a statewide trial.
    
    New South Wales Public Health Bulletin 2006;17(5-6):81-5.
29. Collignon P, Wilkinson I, Gilbert GL, Grayson L, Whitby M.
    
    Healthcare associated Staphylococcus aureus blood stream infections – a clinical quality indicator for all hospitals.
    
    Medical Journal of Australia. 2006;184:404-6.
30. Kong F, Brown M, Sabananthan A, Zeng X, Gilbert GL.
    
    A multiplex PCR-based reverse line blot (mPCR-RLB) hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes.
    
    Journal of Clinical Microbiology 2006;44(5):1887-91 (IF 3.445).
31. O'Sullivan MV, Cai Y, Kong F, Zeng X, Gilbert GL.
    
    Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.
    
    Journal of Clinical Microbiology 2006;44(11):4072-6. (IF 3.445)
32. Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C, Fielding JE, Holland R, Giele C, Gilmour R, Kampen R, Brown M, Gilbert L,
    
    Hogg G, Murphy D. Invasive pneumococcal disease in Australia, 2004.
    
    Communicable Diseases Intelligence 2006;30(1):80-92.
33. Seale H, Macintyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert L.
    
    National serosurvey of cytomegalovirus in australia.
    
    Clinical & Vaccine Immunology 2006;13(11):1181-4.
34. Wen L, Wang Q, Li Y, Kong F, Gilbert GL, Cao B, et al.
    
    Use of a serotype-specific DNA Microarray for identification of group B streptococcus (Streptococcus agalactiae).
    
    Journal of Clinical Microbiology 2006;44:1447-52.
35. Xiong L, Kong F, Zhou H, Gilbert GL.
    
    Use of PCR and reverse line blot hybridization assay for rapid simultaneous detection and serovar identification of Chlamydia trachomatis.
    
    Journal of Clinical Microbiology 2006;44(4):1413-8.
36. Xiong L, Kong F, Yang Y, Cheng J, Gilbert GL.
    
    Use of PCR and reverse line blot hybridization macroarray based on 16S-23S rRNA gene internal transcribed spacer sequences for rapid identification of 34 Mycobacterium species.
    
    Journal of Clinical Microbiology 2006;44(10):3544-50.(IF 3.445)
37. Zeng X, Kong F, Wang H, Darbar A, Gilbert GL.
    
    Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay.
    
    Antimicrobial Agents & Chemotherapy 2006;50(1):204-9. (IF 4.153)
38. Zeng X, Kong F, Morgan J, Gilbert GL.
    
    Evaluation of a multiplex PCR-based reverse line blot-hybridization assay for identification of serotype and surface protein antigens of Streptococcus agalactiae.
    
    Journal of Clinical Microbiology 2006;44(10):3822-5.(IF 3.445)
39. Zhao Z, Kong F, Gilbert GL.
    
    Reverse line blot assay for direct identification of seven Streptococcus agalactiae major surface protein antigen genes.
    
    Clinical & Vaccine Immunology: 2006;13(1):145-9.
40. Zhao Z, Kong F, Martinez G, Zeng X, Gottschalk M, Gilbert GL.
    
    Molecular serotype identification of Streptococcus agalactiae of bovine origin by multiplex PCR-based reverse line blot (mPCR/RLB) hybridization assay.
    
    FEMS Microbiology Letters 2006;263(2):236-9
41. Unicomb LE, Ferguson J, Stafford R J, Ashbolt R, Kirk MD, Becker NG, Patel MS, Gilbert GL, Valcanis M, Mickan L.
    
    Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia.
    
    Clinical Infectious Diseases. 2006;42(10):1368-74.
42. Sintchenko V, Jelfs P, Dally M, Crighton T. Gilbert GL.
    
    Urinary tuberculosis due to Mycobacterium bovis subsp. Caprae
    
    Pathology 2006;38: 376-7
43. Backhouse JL, Gidding HF, MacIntyre CR, McIntyre PB, Gilbert GL.
    
    Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
    
    Vaccine 2007;25(7):1310-5. (IF 3.159)
44. Bishop EJ, Shilton C, Benedict S, Kong F, Gilbert GL, Gal D, et al.
    
    Necrotizing fasciitis in captive juvenile Crocodylus porosus caused by Streptococcus agalactiae: an outbreak and review of the animal and human literature.
    
    Epidemiology & Infection 2007;135(8):1248-55. (IF 1.809)
45. Cai Y, Kong F, Wang Q, Tong Z, Sintchenko V, Zeng X, Gilbert GL.
    
    Comparison of single- and multilocus sequence typing and toxin gene profiling for characterization of methicillin-resistant Staphylococcus aureus.
    
    Journal of Clinical Microbiology 2007;45(10):3302-8. (IF 3.445)
46. Cai Y, Kong F, Gilbert GL.
    
    Three new macrolide efflux (mef) gene variants in Streptococcus agalactiae.
    
    Journal of Clinical Microbiology 2007;45(8):2754-5. (IF 3.445)
47. Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, Quinn H, McIntyre PB.
    
    Sustained measles elimination in Australia and priorities for long term maintenance.
    
    Vaccine 2007;25(18):3574-80. (IF 3.159)
48. Hoile R, Yuen M, James G, Gilbert GL.
    
    Evaluation of the rapid analyte measurement platform (RAMP) for the detection of Bacillus anthracis at a crime scene.
    
    Forensic Science International 2007;171(1):1-4. (IF 1.397)
49. Merritt TD, Sintchenko V, Jelfs P, Worthing M, Robinson B, Durrheim DN, Gilbert GL.
    
    An outbreak of pulmonary tuberculosis in young Australians.
    
    Medical Journal of Australia 2007;186(5):240-2.
50. Ridda I, MacIntyre RC, Lindley RI, McIntyre PB, Sullivan J, Gilbert G, Kovoor P, Manolias N, Fox J.
    
    Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia.
    
    Human Vaccines 2007;3(3):83-6.
51. Sintchenko V, Iredell JR, Gilbert GL.
    
    Pathogen profiling for disease management and surveillance.
    
    Nature Reviews Microbiology 2007:5(6) 464-70. (IF 15.845)
52. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL.
    
    Serotype IX, a proposed new Streptococcus agalactiae serotype.
    
    Journal of Clinical Microbiology 2007;45(9):2929-36. (IF 3.445)
53. Wang Q, Wang M, Kong F, Gilbert GL, Cao B, Wang L, et al.
    
    Development of a DNA microarray to identify the Streptococcus pneumoniae serotypes contained in the 23-valent pneumococcal polysaccharide vaccine and closely related serotypes.
    
    Journal of Microbiological Methods 2007;68(1):128-36.(IF 2.318)
54. Tong Z, Kong F, Wang B, Zeng X, Gilbert GL.
    
    A practical method for subtyping of Streptococcus agalactiae serotype III, of human origin, using rolling circle amplification.
    
    Journal of Microbiological Methods 2007;70(1):39-44. (IF 2.318)
55. Zhou F, Kong F, Tong Z, Gilbert GL.
    
    Identification of less-common Streptococcus pneumoniae serotypes by a multiplex PCR-based reverse line blot hybridization assay.
    
    Journal of Clinical Microbiology 2007;45(10):3411-5. (IF 3.445)
56. Sintchenko V, Gilbert GL.
    
    Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: A decision analysis.
    
    Tuberculosis 2007;87:176-84
57. Darbar A, Gilbert GL.
    
    Phenotypical and genotypical characteristics of invasive group B streptococcus isolates in Western Sydney 2000-2005.
    
    Pathology 2007;39 (6) 589-93.
58. Wang Y, Kong F, Gilbert GL, Brown M, Gao W, Yu S, Yang Y.
    
    Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridization assay for the rapid identification of bacterial pathogens.
    
    Clinical Microbiology and Infection 2008; 14(2) 155-160. doi: 10.1111/j.1469-0691.2007.01890.x (IF 3.254)
59. Fernandes, CJ, O'Sullivan MV, Cai Y, Kong F, Zeng X, Gilbert GL, Kotsiou G.
    
    An agar dilution method for the detection of inducible clindamycin resistance in Staphylococcus spp.
    
    Journal of Clinical Microbiology 2007;45:4018-20. (IF 3.445)
60. Wang Y, Yang U, Kong F, Gilbert GL.
    
    A multiplex PCR-based reverse line blot hybridization (mPCR/RLB) assay for detection of bacterial respiratory pathogens in children with pneumonia.
    
    Pediatric Pulmonology 2008;43:150-9.
61. Gidding HF. Warlow M. MacIntyre CR. Backhouse J. Gilbert GL. Quinn HE. McIntyre PB.
    
    The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    
    Vaccine 2007: 25(51):8637-41
62. Zhao, Z., Kong F, Zeng X, Gidding H, Morgan J, Gilbert GL.
    
    Molecular serotype and antibiotic resistance markers among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australia and New Zealand.
    
    Clinical Microbiology and Infection 2008; 14 (3): 260-267 (IF 3.254)
63. Unicomb LE, Dalton CB, Gilbert GL, Becker NG, Patel M, and the Australian Campylobacter Subtyping Group
    
    Risk factors for sporadic Campylobacter infection in the Hunter Region New South Wales, Australia.
    
    Foodborne Pathogens and Disease 2008; 5(1)2:79-85.
64. Kong F,1 Lambertsen LM, Slotved H-C, Ko D, Wang H, Gilbert GL.
    
    Use of phenotypic and molecular serotype identification methods to characterise previously non-serotypeable group B streptococci (GBS).
    
    J Clin Microbiol 2008 (in press)
65. Unicomb LE, O'Reilly LC, Kirk MD, Stafford RJ, Smith HV, Becker NG, Patel MS, Gilbert GL.
    
    Risk factors for infection with Campylobacter jejuni flaA genotypes.
    
    Epidemiology and Infection 2008 (in press – accepted 4-12-08) (IF 1.809)
66. Pendle S. Jelfs P, Olma T, Su Y, Gilroy N, Gilbert GL
    
    Significant discrepancies between different methods for laboratory identification of vancomycin resistant E. faecium (VRE)
    
    Clin Microbiol Infect (in press)
67. Newall, A.T., Brotherton, J.M.L., Quinn, H.E., Backhouse, J., McIntyre, P.B., Gilbert G.L., Esser, M.T., Erick, J., Bryan, J., Formica, N., MacIntyre, C.R.
    
    Population prevalence of exposure to human papillomavirus types 6, 11, 16, and 18 in men, women and children in Australia.
    
    Clin Infect Dis (in press).
68. Moujaber T, Backhouse J, Gidding H, Quinn H, Gilbert GL, MacIntyre CR.
    
    The seroepidemiology of Helicobacter pylori infection in Australia.
    
    International Journal of Infectious Diseases 2008 (in press – accepted 29-1-08).
69. Wang Q, Kong F, Jelfs P, Gilbert GL.
    
    Extended phage locus typing of Salmonella enterica serovar Typhimurium, using multiplex PCR-based reverse line blot hybridization.
    
    J Med Microbiol 2008 (in press - accepted 17-2-08).
70. Aratchige PE, Quinn H, Gilbert GL, McIntyre PB.
    
    Recent increases in mumps incidence in Australia - the "forgotten" age group in the 1998 Measles Control Campaign.
    
    Med J Aust, 2008 (in press).
71. Wang Q, Chiew R, Howard P, Gilbert GL.
    
    Salmonella Typing in New South Wales: Current methods and application of improved epidemiological tools,
    
    NSW Public Health Bulletin 2008 (in press – accepted 16-1-08).
72. Gallego B, Sintchenko V, Wang Q, Hiley L, Gilbert GL, Coiera E.
    
    Biosurveillance of emerging biothreats using scalable genotype clustering.
    
    J Biomed Informatics 2008 (in press – accepted May 2008)

Invited Reviews and Editorials

1. Gilbert GL.
   
   Preventing perinatal B streptococcal infection: the jury is still out.
   
   Medical Journal of Australia 2003;178(5):199-200 (Editorial).
2. Gilbert GL.
   
   Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?
   
   Expert Review of Vaccines 2004;3(4):371-4
3. Nguyen LN, Gilbert GL, Marks GB.
   
   Molecular epidemiology of tuberculosis and recent developments in understanding the epidemiology of tuberculosis.
   
   Respirology 2004;9:313-9.
4. Gilbert L.
   
   In that case: response.
   
   Journal of Bioethical Inquiry 2005;2(1):55.
5. Gilbert L.
   
   Laboratory diagnosis of communicable diseases - pitfalls and prospects.
   
   New South Wales Public Health Bulletin 2006;17(3-4):52-6.
6. Gilbert GL
   
   A resistant culture – “superbugs” in Australian hospitals.
   
   Microbiology Australia 2007; 26:182-185. (Invited Review)
7. Gilbert GL.
   
   In that case: response: Public health dilemmas concerning a two-year-old hepatitis-B carrier.
   
   Journal of Bioethical Inquiry 2008 (in press – accepted 30-1-08). (Invited Comment)
8. Wang Q, Chiew R, Kong F, Howard P, Gilbert GL.
   
   Salmonella typing in New South Wales: current methods and application of improved epidemiological tools.
   
   NSW Public Health Bulletin,2008;19:24-8
9. Gilbert, G.L.
   
   Using MLVA to type strains of Salmonella Typhimurium in New South Wales.
   
   New South Wales Public Health Bulletin, 2008;19;29-31.
10. Gilbert, G.L.
    
    Improving foodborne disease surveillance in NSW (Editorial).
    
    New South Wales Public Health Bulletin, 2008; 19; 1-2 (Guest Editorial).

Book Chapters

1. Gilbert G.L. O’Reilly M, Garland SM.
   
   Infectious Diseases in the Pregnant Woman and her Infant.
   
   In Infectious Diseases: A Clinical Approach. Yung A, et al (Eds) 2005
2. Gilbert G.L.
   
   Rat Bite Fever.
   
   In Conn’s Current Therapeutics 2005 Rakel RE, Editor. WB Saunders 2005.

Letters

1. Tarnow-Mordi W, Isaacs D, Gilbert G, Athayde N, Stanley F.
   
   Effect of oral clindamycin on late miscarriage and preterm delivery.[comment].
   
   Lancet 2003;361(9375):21. (IF 25.8)
2. Gilbert GL, Gidding HF, Backhouse J, McIntyre PB.
   
   Varicella seroprevalence and vaccine uptake in preschool children.
   
   Medical Journal of Australia 2005;182(1):3.
3. Sintchenko V, Brown M, Gilbert GL.
   
   Is Bordetella pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971-2006.
   
   Journal of Antimicrobial Chemotherapy 2007;60(5):1178-9. (IF 3.891)

IREDELL

2008

1. Espedido BA, Partridge SR, Iredell JR.
   
   bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
   
   Antimicrob Agents Chemother. 2008 Aug;52(8):2984-7. Epub 2008 May 19. PMID: 18490506 [PubMed - in process]
2. Treerat P, Widmer F, Middleton PG, Iredell J, George AM.
   
   In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
   
   FEMS Microbiol Lett. 2008 May 29. [Epub ahead of print] PMID: 18513356 [PubMed - as supplied by publisher]
3. Syrmis M, Bell S, Bye P, Coulter C, Harbour C, Iredell J, Kidd T, O'Carroll M, Rose B, Wainwright C, Sloots T, Nissen M.
   
   High prevalence of a class 1 integron-associated aadB gene cassette in Pseudomonas aeruginosa isolates from an Australian cystic fibrosis patient population.
   
   Pathology. 2008 Aug;40(5):524-525. No abstract available. PMID: 18604741 [PubMed - as supplied by publisher]
4. Lau A, Sorrell TC, Chen S, Stanley K, Iredell J, Halliday C.
   
   Multiplex Tandem PCR: a Novel Platform for Rapid Detection and Identification of Fungal Pathogens from Blood Culture Specimens.
   
   J Clin Microbiol. 2008 Sep;46(9):3021-7. Epub 2008 Jul 16. PMID: 18632914 [PubMed - in process]
5. Zong Z, Partridge SR, Thomas L, Iredell JR.
   
   Dominance of blaCTX-M within an Australian ESBL gene pool.
   
   Antimicrob Agents Chemother. 2008 Aug 25. [Epub ahead of print] PMID: 18725449 [PubMed - as supplied by publisher]
6. Xu X, Kong F, Cheng X, Yan B, Du X, Gai J, Ai H, Shi L, Iredell J.
   
   Integron gene cassettes in Acinetobacter spp. strains from South China.
   
   Int J Antimicrob Agents. 2008 Aug 29. [Epub ahead of print] PMID: 18757181 [PubMed - as supplied by publisher]
7. Bouchillon S, Lee K, Barkham T, Iredell JR
   
   Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
   
   Int J Antimicrob Agents accepted July 08)

2007

1. Iredell J, Thomas L, Espedido B.
   
   Beta-lactam resistance in the gram negatives: increasing complexity of conditional, composite and multiply resistant phenotypes.
   
   Pathology. 2006 Dec;38(6):498-506.
2. Thomas LC, Gidding HF, Ginn AN, Olma T, Iredell J.
   
   Development of a real-time Staphylococcus aureus and MRSA (SAM-) PCR for routine blood culture.
   
   J Microbiol Methods. 2007 Feb;68(2):296-302. Epub 2006 Oct 12. PMID: 17046087 [PubMed - indexed for MEDLINE]
3. Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J.
   
   Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii.
   
   J Clin Microbiol. 2007 Feb;45(2):453-60. Epub 2006 Nov 15. PMID: 17108068 [PubMed - indexed for MEDLINE]
4. Playford EG, Craig JC, Iredell JR.
   
   Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.
   
   J Hosp Infect. 2007 Mar;65(3):204-11. Epub 2007 Jan 23. PMID: 17254667 [PubMed - indexed for MEDLINE]
5. Chatterjee I, Iredell JR, Woods M, Lipman J.
   
   The implications of enterococci for the intensive care unit.
   
   Crit Care Resusc. 2007 Mar;9(1):69-75. Review. PMID: 17352670 [PubMed - indexed for MEDLINE]
6. Iredell J, Thomas L, Power D, Mendes E.
   
   Tigecycline resistance in Australian antibiotic-resistant Gram-negative bacteria.
   
   J Antimicrob Chemother. 2007 Apr;59(4):816-8. Epub 2007 Mar 12. No abstract available. PMID: 17353224 [PubMed - indexed for MEDLINE]
7. Espedido BA, Thomas LC, Iredell JR.
   
   Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing.
   
   J Clin Microbiol. 2007 Jun;45(6):2034-6. Epub 2007 Apr 4. PMID: 17409217 [PubMed - indexed for MEDLINE]
8. Sintchenko V, Iredell JR, Gilbert GL.
   
   Pathogen profiling for disease management and surveillance.
   
   Nat Rev Microbiol. 2007 Jun;5(6):464-70. Epub 2007 May 8. PMID: 17487146 [PubMed - indexed for MEDLINE]

2006

1. Valenzuela, J, Thomas, L, Partridge, S, van der Reijden, T, Dijkshoorn, L, Iredell, J.
   
   Horizontal gene transfer within a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii.
   
   Journal of clinical microbiology. 2006; 0:0
2. Thomas, L, Gidding, H, Ginn, A, Olma, T, Iredell, J.
   
   Development of a real-time Staphylococcus aureus and MRSA (SAM-) PCR for routine blood culture.
   
   Journal of microbiological methods. 2006; 0:0
3. Iredell, J, Sintchenko, V.
   
   Screening for antibiotic resistant Gram-negative bacteria.
   
   The Lancet infectious diseases. 2006. p. 316-7.
4. Pendle, S, Ginn, A, Iredell, J.
   
   Antimicrobial susceptibility of Bartonella henselae using Etest methodology.
   
   The Journal of antimicrobial chemotherapy. 2006; 57:761-3

2005

1. Espedido, B, Iredell, J, Thomas, L, Zelynski, A.
   
   Wide dissemination of a carbapenemase plasmid among gram-negative bacteria: implications of the variable phenotype.
   
   Journal of clinical microbiology. 2005. p. 4918-9.
2. Cachia, A, Eshoo, S, Kench, J, Fung, C, Jones, A, Iredell, J, Don, G.
   
   Synchronous malakoplakia and Whipple's disease.
   
   Pathology. 2005. p. 315-7.
3. Dillon, B, Thomas, L, Mohmand, G, Zelynski, A, Iredell, J.
   
   Multiplex PCR for screening of integrons in bacterial lysates.
   
   Journal of microbiological methods. 2005; 62:221-32
4. Kyme, P, Haas, A, Schaller, M, Peschel, A, Iredell, J, Kempf, V.
   
   Unusual trafficking pattern of Bartonella henselae-containing vacuoles in macrophages and endothelial cells.
   
   Cellular Microbiology. 2005; 7:1019-1034
5. Thomas, L, Espedido, B, Watson, S, Iredell, J, , A.
   
   Forewarned is forearmed: antibiotic resistance gene surveillance in critical care.
   
   The Journal of hospital infection. 2005. p. 291-3.
6. Iredell, J, Lipman, J.
   
   Antibiotic resistance in the intensive care unit: a primer in bacteriology.
   
   Anaesthesia and intensive care. 2005; 33:188-95
7. Sintchenko, V, Iredell, J, Gilbert, G, Coiera, E.
   
   Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.
   
   Journal of the American Medical Informatics Association: JAMIA. 2005; 12:398-402

2004

1. Dillon, B, Iredell, J.
   
   DdeI RFLP for 16S rDNA typing in Bartonella henselae.
   
   Journal of medical microbiology. 2004. p. 1263-5.
2. Rodrick, D, Dillon, B, Dexter, M, Nicholson, I, Marcel, S, Dickeson, D, Iredell, J.
   
   Culture-negative endocarditis due to Houston Complex Bartonella henselae acquired in Noumea, New Caledonia.
   
   Journal of clinical microbiology. 2004; 42:1846-8
3. Sintchenko, V, Coiera, E, Iredell, J, Gilbert, G.
   
   Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases.
   
   Journal of the American Medical Informatics Association : JAMIA. 2004; 11:71-7

2003

1. Iredell, J, Blanckenberg, D, Arvand, M, Grauling, S, Feil, E, Birtles, R.
   
   Characterization of the natural population of bartonella henselae by multilocus sequence typing.
   
   Journal Of Clinical Microbiology. 2003; 41:5071-5079
2. Kyme, P, Dillon, B, Iredell, J.
   
   Phase variation in bartonella henselae.
   
   Microbiology-Sgm. 2003; 149:621-629

2002

1. Dillon, B, Valenzuela, J, Don, R, Blanckenberg, D, Wigney, D, Malik, R, Morris, A, Robson, J, Iredell, J.
   
   Limited Diversity among Human isolates of Bartonella henselae.
   
   Journal Of Clinical Microbiology. 2002; 40:4691-4699
2. Arora, S, Mudaliar, Y, Lee, C, Mitchell, D, Iredell, J, Lazarus, R.
   
   Non-Bronchoscopic Bronchoalveolar Lavage in the Microbiological Diagnosis of Pneumonia in Mechanically Ventilated Patients.
   
   Anaesthesia And Intensive Care. 2002; 30:11-20
3. Kyme, P, Dillon, B, Iredell, J.
   
   Phase variation in Bartonella heselae.
   
   Microbiology. 2002; 149:621-629
4. Iredell, J, McHattan, J, Kyme, P, Dillon, B, Blanckenberg, D.
   
   Antigenic and Genotypic Relationships between Bartonella henselae Strains.
   
   Journal Of Clinical Microbiology. 2002; 40:4397-4398

2001

1. Sintchenko, V, Iredell, J, Gilbert, G.
   
   Antibiotic therapy of ventilator-associated pneumonia - a reappraisal of rationale in the era of bacterial resistance.
   
   International Journal of Antimicrobial Agents. 2001; 33:287-291
2. Sintchenko, V, Iredell, J, Gilbert, G, Coiera, E.
   
   What do physicians think about evidence-based antibiotic use in critical care? A survey of Australian intensivists and infectious disease practitioners.
   
   Internal Medicine Journal. 2001; 181(6):492-498

2000

1. Dillon, B, Cagney, M, Manolios, N, Iredell, J.
   
   Failure to detect bartonella henselae infection in synovial fluid from sufferers of chronic arthritis.
   
   Rheumatology International. 2000; 19:219-222
2. Sorrell, T, Iredell, J, Mitchell, D.
   
   Higher bacterial diseases.
   
   In: Principles and Practice of Infectious Diseases, 5th edn. : Churchill Livingstone 2000. p. 2637-2645.
3. Learmont, J, Raynes-Greenow, C, Branley, J, Frankum, B, Maddocks, S, Iredell, J.
   
   Late diagnosis of three cases of transfusion-acquired HIV-1 infection.
   
   Medical Journal of Australia. 2000; 172:349-349

MEYER

1. Kaocharoen S, Wang B, Tsui KM, Trilles L, Kong F, Meyer W (in press)
   
   Rolling circle amplification as a rapid and sensitive method for species identification within the Cryptococcus species complex.
   
   Electrophoresis, accepted 16.04.2008
2. Trilles L, Lazéra dos Santos M, Wanke B, Vasconcelo-Oliveira R, Gonçalves-Barbosa G, Penarrieta-Morales B, Meyer W (in press)
   
   Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil.
   
   Memorias do Instituto Oswaldo Cruz, accepted 12.05.2008
3. Ngamskulrungroj P, Sorrell TC, Chindamporn A, Chaiprasert A, Poonwan N, Meyer W (in press)
   
   Association between fertility and molecular sub-type of global isolates of Cryptococcus gattii molecular type VGII.
   
   Medical Mycology, accepted 19.05.2008
4. Hanafy A, Jover-Botella A, Katsu M, Iida S, Kogure T, Gonoi T, Mikami Y, Meyer W (in press)
   
   Multilocus Microsatellite Typing for Cryptococcus neoformans var. grubii.
   
   Medical Mycology, accepted 3.3.2008
5. Karaoglu H, Lee CMY, Carter D, Meyer W (in press)
   
   Development of polymorphic microsatellite markers for Cryptococcus neoformans.
   
   Molecular Ecology Notes, accepted 11.02.2008
6. Tsui CKM, Daniel HM, Robert V, Meyer W (2008)
   
   Re-examining the phylogeny of clinically relevant Candida species and allied genera based on multigene analyses.
   
   FEMS yeast research 8: 651-659.
7. Delhaes L, Harun A, Chen SCA, Nguyen Q, Slavin M, Heath CH, Maszewska K, Halliday C, Robert V, Sorrell TC, The Australian Scedosporium (AUSCEDO) Study Group & Meyer W (2008)
   
   Molecular typing of Australian Scedosporium isolates reveals genetic variability and a substantial number of S. aurantiacum.
   
   Journal of Emerging Infectious Diseases 14(2): 282-290.
8. Escondón P, Ngamskulrungroj P, Meyer W, Castañeda E (2007)
   
   In vitro mating of Colombian isolates of the Cryptococcus neoformans speciies complex.
   
   Biomedica 27 (2): 308-314
9. Meyer W (2007)
   
   The emergence of Cryptococcus gattii VGII as a super killer?
   
   Microbiology Australia 28 (2): 70-71
10. Ribeiro AM, Rosa e Silva, LK, Schrank IS, Schrank A, Meyer W, Henning Vainstein M (2006)
    
    Isolation of Cryptococcus neoformans var. neoformans serotype D from Eucalypts in South Brazil
    
    Medical Mycology, Medical Mycology, 44:707-713.
11. Meyer W, Pearce C (2006)
    
    Proceedings of the 8th International Mycological Congress, Cairns, Australia, 20-25.8.2006
    
    MEDIMOND, Italie (ISBN 88-7587276-7)
12. Kluger EK, Karaoglu HK, Krockenberger MB, Della Torre PK, Meyer W, Malik R (2006)
    
    Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13 year period in a Birman cat
    
    Medical Mycology, 44:561-566.
13. Escandon P, Sanchez A, Martinez M, Meyer W & Castañeda E (2006)
    
    Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia
    
    FEMS Yeast Research 6: 625-635.
14. Campbell LT, Currie BJ. Krockenberger M, Malik R, Meyer W, Heitman J & Carter Dee (2005)
    
    Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii
    
    Eukaryotic Cell 4(8): 1403-1409.
15. Karaoglu H, Lee CMY & Meyer W (2005)
    
    Survey of Simple Sequence Repeats in completed Fungal Genomes
    
    Molecular Biology and Evolution, MBE 22(3): 639-649.
16. Kidd S, Hagen F, Tscharke R, Huynh M, Bartlett K, Fyfe M, MacDougall L, Boekhout T, Kwon-Chung JK & Meyer W (2004)
    
    A rare genotype of Cryptococcus gattii caused the Cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)
    
    PNAS 107(49): 17258-17263 [Evaluated by Faculty 1000: http://www.f1000biology.com/article/15572442/evaluation]
17. Mahoney D, Gams W, Meyer W & Starink M (2004)
    
    Umbelopsis dimorpha n. sp., a link between U. vinacea and U. versiformis
    
    Mycological Research 108(1): 107-111.
18. Igreja RP, Lazera M dos S, Wanke B, Galhardo MCG, Kidd S & Meyer W (2004)
    
    PCR-fingerprinting of Cryptococcus neoformans isolates from AIDS patients of the city of Rio de Janeiro.
    
    Medical Mycology 42: 229-238
19. Katsu M, Kidd S, Ando A, Moretti-Branchini ML, Mikami Y, Nishimura K & Meyer W (2004)
    
    The Internal Transcribed Spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex.
    
    FEMS Yeast Research 4: 377-388.
20. Lachance MA, Daniel HM, Meyer W, Prasad GS, Gautam SP & Boundy-Mills K (2003)
    
    The D1/D2 domain of the large subunit rDNA of the yeast species Clavspora lusitaniae is unusually polymorphic.
    
    FEMS Yeast Research 4 (3): 253-258.
21. Daniel HM & Meyer W (2003)
    
    Evaluation of ribosomal RNA and actin gene sequences for the identification of ascomycetous yeasts.
    
    J. International Food Microbiology 86: 61-78.
22. Casali AK, Goulart L, Rosa e Silva LK, Ribeiro AM, Amaral AA, Alves SH, Schrank A, Meyer W, & Vainstein MH (2003)
    
    Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian State Rio Grande do Sul.
    
    FEMS Yeast Research 3 (4): 405-415.
23. Latouche GN, Huynh M, Sorrell TC & Meyer W (2003)
    
    PCR-restriction fragment length polymorphism analysis of the phopholipase B gene (PLB1) for subtyping of Cryptococcus neoformans isolates.
    
    App. Environ. Micorbiol.69 (4): 2080-2086.
24. Meyer W and Gams W (2003)
    
    Approaches to the classification of the Mortierella isabellina-group (Mucorales). 2. Delimitation of Umbelopsis based on ITS sequences and RFLP data.
    
    Mycological Research 107(3): 339-350.
25. Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E and the IberoAmerican Cryptococcal Study Group (2003)
    
    Molecular typing of IberoAmerican Cryptococcus neoformans Isolates
    
    Emerging Infect. Dis.: 9(2): 189-195.
26. Kidd SE, Sorrell TC, Meyer W (2003)
    
    A potential environmental association between Cryptococcus neoformans var. gattii and insect frass.
    
    Medical Mycology 41(2): 171-176.

MINDEL

2008

1. Mindel A, Sawleshwarkar S.
   
   Condoms for sexually transmissible infection prevention: politics versus science.
   
   Sex Health 2008;5(1):1-8.

2007

1. Corey, L., Bodsworth, N., Mindel, A., Patel, R., Schacker, T., Stanberry, L.
   
   An update on short-course episodic and prevention therapies for herpes genitalis. Herpes : the journal of the IHMF.
   
   2007; 14 Suppl 1:5A-11A.
2. McCarthy, M., Haddow, L., Furner, V., Mindel, A.
   
   Contact tracing for sexually transmitted infections in New South Wales, Australia.
   
   Sexual health. 2007; 4:21-25.
3. Smit, C., Pfrommer, C., Mindel, A., Taylor, J., Spaargaren, J., Berkhout, B., Coutinho, R., Dukers, N.
   
   Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and HIV over time (1984-2003).
   
   European journal of epidemiology. 2007; 22:937-44.

2006

1. Kang, M., Rochford, A., Johnston, V., Jackson, J., Freedman, E., Brown, K., Mindel, A.
   
   Prevalence of Chlamydia trachomatis infection among 'high risk' young people in New South Wales.
   
   Sexual Health. 2006; 3:253-4.
2. Jin, F., Prestage, G., Mao, L., Kippax, S., Pell, C., Donovan, B., Templeton, D., Taylor, J., Mindel, A., Kaldor, J., Grulich, A.
   
   Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study.
   
   The Journal of infectious diseases. 2006; 194:561-70.
3. Haddow, L., Sullivan, E., Taylor, J., Abel, M., Cunningham, A., Tabrizi, S., Mindel, A.
   
   Herpes Simplex Virus Type 2 (HSV-2) Infection in Women Attending an Antenatal Clinic in the South Pacific Island Nation of Vanuatu.
   
   Sexually transmitted diseases. 2006; 0:0.
4. Davies, S., Taylor, J., Sedyaningsih-Mamahit, E., Gunawan, S., Cunningham, A., Mindel, A.
   
   Prevalence and Risk Factors for Herpes Simplex Virus Type 2 Antibodies Among Low- and High-Risk Populations in Indonesia.
   
   Sexually transmitted diseases. 2006; 0:0.
5. Garland, S., Waddell, R., Mindel, A., Denham, I., McCloskey, J., , T.
   
   An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
   
   International journal of STD & AIDS. 2006; 17:448-52.
6. Haddow, L., Dave, B., Mindel, A., McPhie, K., Chung, C., Marks, C., Dwyer, D.
   
   Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003.
   
   Sexually transmitted infections. 2006; 82:255-9.
7. Fox, J., Tideman, R., Gilmour, S., Marks, C., van Beek, I., Mindel, A.
   
   Sex work practices and condom use in female sex workers in Sydney.
   
   International journal of STD & AIDS. 2006; 17:319-23.
8. Cunningham, A., Taylor, R., Taylor, J., Marks, C., Shaw, J., Mindel, A.
   
   Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.
   
   Sexually transmitted infections. 2006; 82:164-8.
9. Haddow, L., Mindel, A.
   
   Genital herpes vaccines--cause for cautious optimism.
   
   Sexual Health. 2006; 3:1-4.
10. Freedman, E., Britt, H., Harrison, C., Mindel, A.
    
    Sexual health problems managed in Australian general practice: a national, cross sectional survey.
    
    Sexually transmitted infections. 2006; 82:61-6.
11. Van der Bij, A., Spaargaren, J., Morré, S., Fennema, H., Mindel, A., Coutinho, R., de Vries, H.
    
    Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study.
    
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006; 42:186-94.

2005

1. Mindel, A., Kippax, S.
   
   A national sexually transmissible infections strategy: the need for an all-embracing approach.
   
   The Medical journal of Australia. 2005; 183:502-3.
2. Mindel, A., Marks, C.
   
   Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management.
   
   CNS drugs. 2005; 19:303-12.

2004

1. Tawk, H., Simpson, J., Mindel, A.
   
   Condom use in multi-partnered males: importance of HIV and hepatitis B status.
   
   AIDS care. 2004; 16:890-900.
2. Johnston, V., Britt, H., Pan, Y., Mindel, A.
   
   The management of sexually transmitted infections by Australian general practitioners.
   
   Sexually transmitted infections. 2004; 80:212-5.
3. Tawk, H., Simpson, J., Mindel, A.
   
   Condom use in multi-partnered females.
   
   International journal of STD & AIDS. 2004; 15:403-7.
4. Fox, J., Weerasinghe, D., Marks, C., Mindel, A.
   
   Emergency contraception: who are the users?.
   
   International journal of STD & AIDS. 2004; 15:309-13.
5. Song, B., Dwyer, D., Mindel, A.
   
   HSV type specific serology in sexual health clinics: use, benefits, and who gets tested.
   
   Sexually transmitted infections. 2004; 80:113-7.
6. Freedman, E., Mindel, A.
   
   Epidemiology of herpes and HIV co-infection.
   
   Journal of HIV therapy. 2004; 9:4-8.
7. Smart, S., Singal, A., Mindel, A.
   
   Social and sexual risk factors for bacterial vaginosis.
   
   Sexually transmitted infections. 2004; 80:58-62.
8. Mindel, A., Freedman, E., Jones, C.
   
   Epidemiological, Clinical and Laboratory Aids for the Diagnosis of Neonatal Herpes - an Australian Perspective.
   
   HERPES. 2004; 11:38-40.

2003

1. Page, J., Taylor, J., Tideman, R., Seifert, C., Marks, C., Cunningham, A., Mindel, A.
   
   Is HSV serology useful for the management of first episode genital herpes?.
   
   Sexually transmitted infections. 2003; 79:276-9.
2. Mindel, A., Marks, C., Tideman, R., Taylor, J., Seifert, C., Berry, G., Trudinger, B., Cunningham, A.
   
   Sexual behaviour and social class in Australian women.
   
   International journal of STD & AIDS. 2003; 14:344-9.
3. Tideman, R., Thompson, C., Rose, B., Gilmour, S., Marks, C., van Beek, I., Berry, G., Oconnor, C., Mindel, A.
   
   Cervical human papillomavirus infections in commercial sex workers - risk factors and behaviours.
   
   International Journal Of Std & Aids. 2003; 14:840-847.

2002

1. Copas, A., Cowan, F., Cunningham, A., Mindel, A.
   
   An evidence based approach to testing for antibody to herpes simplex virus type 2.
   
   Sexually transmitted infections. 2002; 78:430-4.
2. Stanberry, L., Spruance, S., Cunningham, A., Bernstein, D., Mindel, A., Sacks, S., Tyring, S., Aoki, F., Slaoui, M., Denis, M., Vandepapeliere, P., Dubin, G.
   
   Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
   
   The New England journal of medicine. 2002; 347:1652-61.

2001

1. Tideman, R., Taylor, J., Marks, C., Seifert, C., Berry, G., Trudinger, B., Cunningham, A., Mindel, A.
   
   Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic.
   
   Sexually transmitted infections. 2001; 77:413-5.
2. Tideman, R., Marks, C., Knight, V., Berry, G., Fethers, K., Mindel, A.
   
   Opting off the New South Wales pap test register in a sexual health setting.
   
   Australian and New Zealand Journal of Public Health. 2001; 25:501-504.
3. Mindel, A., Tenant-Flowers, M.
   
   ABC of AIDS Natural history and management of early HIV infection.
   
   British Medical Journal. 2001; 25 (7-8):669-678.
4. Coughlan, E., Mindel, A., Estcourt, C.
   
   Male clients of female commercial sex workers: HIV, STDs and risk behaviour.
   
   Div John Wiley & Sons Inc,605 Third Ave, New York, Ny, 10158-0012: Wiley-Liss, 2001.
5. Gilson, R., Mindel, A.
   
   Recent advances sexually transmitted infections.
   
   British Medical Journal. 2001; 41:320-325.
6. Mindel, A., Estcourt, C.
   
   Sexual health education for male sex workers.
   
   Lancet. 2001; 52:863-870.
7. Buchanan, D., Mindel, A.
   
   Should people with a viral sexually transmissible infection be aided to have sexual intercourse?.
   
   In: Venereology. Cambridge, UK: Cambridge University Press 2001. p. 259-268.
8. Trutnovsky, G., Law, C., Simpson, J., Mindel, A.
   
   Use of complementary therapies in a sexual health clinic setting.
   
   International Journal of Std & Aids. 2001; 36 No 3:219-226.

2000

1. Butler, T., Donovan, B., Taylor, J., Cunningham, A., Mindel, A., Levy, M., Kaldor, J.
   
   Herpes simplex virus type 2 in prisoners, New South Wales, Australia.
   
   International journal of STD & AIDS. 2000; 11:743-7.
2. Marks, C., Tideman, R., Estcourt, C., Berry, G., Mindel, A.
   
   Assessment of risk for pelvic inflammatory disease in an urban sexual health population.
   
   Sexually Transmitted Infections. 2000; 76:470-473.
3. Estcourt, C., Marks, C., Rohrsheim, R., Johnson, A., Donovan, B., Mindel, A.
   
   HIV, sexually transmitted infections, and risk behaviours in male commercial sex workers in Sydney.
   
   Sexually Transmitted Infections. 2000; 76:294-298.
4. Mindel, A., Taylor, J., Tideman, R., Seifert, C., Berry, G., Wagner, K., Page, J., Marks, C., Trudinger, B., Cunningham, A.
   
   Neonatal herpes prevention: a minor public health problem in some communities.
   
   Sexually Transmitted Infections. 2000; 76:287-291.
5. Stanberry, L., Cunningham, A., Mindel, A., Scott, L., Spruance, S., Aoki, F., Lacey, C.
   
   Prospects for control of Herpes Simplex virus disease through immunization.
   
   Clinical Infectious Diseases. 2000; 30:549-566.

O'SULLIVAN

1. Eisen DP, Dean MM, O'Sullivan MV, Heatley S, Minchinton RM.
   
   Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients.
   
   Med Mycol. 2008 Jun;46(4):371-5.
2. Fernandes CJ, O'Sullivan MV, Cai Y, Kong F, Zeng X, Gilbert GL, Kotsiou G.
   
   Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp.
   
   J Clin Microbiol. 2007 Dec;45(12):4018-20.
3. O'Sullivan MV, Cai Y, Kong F, Zeng X, Gilbert GL.
   
   Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.
   
   J Clin Microbiol. 2006 Nov;44(11):4072-6.
4. Ralph A, O'Sullivan MV, Sangster NC, Walker JC.
   
   Abdominal pain and eosinophilia in suburban goat keepers--trichostrongylosis.
   
   Med J Aust. 2006 May 1;184(9):467-9.
5. Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrell T.
   
   Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis.
   
   Clin Infect Dis. 2005 Dec 1;41(11):1582-90.
6. O'Sullivan MV, Isbel NM, Johnson DW, Rencken K, Byrne S, Graham MM, Playford EG.
   
   Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction.
   
   Clin Infect Dis. 2004 Nov 1;39(9):e98-9.
7. O'Sullivan MV, Whitby M, Chahoud C, Miller SM.
   
   Histoplasmosis in Australia: a report of a case with a review of the literature.
   
   Aust Dent J. 2004 Jun;49(2):94-7.

RUSSELL

RESEARCH ARTICLES

1. RUSSELL, R.C. (1998).
   
   Arboviruses in Australia - the current scene and implications of climate change for human health.
   
   International Journal for Parasitology, 28: 955-969.
2. RUSSELL, R.C. (1998).
   
   Vectors vs Humans in Australia - Who is on top down under? (An update on vector-borne disease and research on vector in Australia).
   
   Journal of Vector Ecology 23 : 1-46.
3. RUSSELL, R.C. and Kuginis, L. (1998).
   
   ‘Mosquito risk assessment and management.’ Pp 181-191 in: ‘The Constructed Wetlands Manual’.
   
   Department of Land and Water Conservation, Sydney. Orbital Offset Press. 424pp.
4. RUSSELL, R.C. (1998).
   
   Constructed wetlands and mosquitoes: health hazards and management options - an Australian perspective.
   
   Ecological Engineering (in press).
5. Gislason, G.M. and RUSSELL, R.C. (1997)
   
   Oviposition sites of the saltmarsh mosquito Aedes vigilax (Skuse) (Diptera: Culicidae) at Homebush Bay, Sydney, NSW - a preliminary investigation.
   
   Australian Journal of Entomology, 36: 97-100.
6. Grattan-Smith, P.J., Morris, J.G., Johnston, H.M., Yiannikas, Y., Malik, R., RUSSELL, R.C. and Ouvrier, R.A. (1997).
   
   Clinical and neurophysiological features of tick paralysis.
   
   Brain, 120: (in press).
7. Hueston, L., Yund, A., Cope, S., Monteville, M., Marchetti, M., Haniotis, J., Clancy, J., Doggett, S., RUSSELL, R., Dwyer, D. and Parker, G. (1997).
   
   Ross River virus in a joint military exercise.
   
   Communicable Diseases Intelligence, 21: 193.
8. Doggett, S., RUSSELL, R., Cloonan, M., Clancy, J. and Haniotis, J. (1996).
   
   Surveillance for arboviruses in mosquitoes in New South Wales, Australia, 1995-96.
   
   Arthropod-Borne Virus Information Exchange, June 1996: 31-32.
9. RUSSELL, R.C. and Brust, R.A. (1996).
   
   Snow-melt alpine mosquitoes (Diptera: Culicidae) in New South Wales.
   
   Australian Journal of Entomology, 35: 113-114.
10. RUSSELL, R.C. and Geary, M.J. (1996).
    
    The influence of microfilarial density of dog heartworm Dirofilaria immitis on infection rate and survival of Aedes notoscriptus and Culex annulirostris from Australia.
    
    Medical and Veterinary Entomology, 10: 29-34.
11. Doggett, S., RUSSELL, R., Cloonan, M., Clancy, J. and Haniotis, J. (1995).
    
    Arbovirus and mosquito activity on the south coast of New South Wales, 1994-95.
    
    Communicable Diseases Intelligence, 19: 473-475.
12. Doggett, S., RUSSELL, R., Cloonan, M., Clancy, J. and Haniotis, J. (1995).
    
    Arbovirus and mosquito activity on the south coast of New South Wales, Australia 1994/95.
    
    Arthropod-Borne Virus Information Exchange, December 1995: 29-32.
13. Doggett, S., RUSSELL, R., Lawrence, R. and Dickeson, D. (1995).
    
    Lyme disease.
    
    Inoculum, 4: 1-4.
14. RUSSELL, R.C. (1995).
    
    Lyme disease in Australia - still to be proven!
    
    Emerging Infectious Diseases, 1: 29-31.
15. RUSSELL, R.C. (1995).
    
    Arboviruses and their vectors in Australia: an update on the ecology and epidemiology of some mosquito-borne arboviruses.
    
    Review of Medical and Veterinary Entomology, 83: 141-158.
16. RUSSELL, R., Cloonan, M., Doggett, S., Clancy, J., Haniotis, J., Wells, P. and Fennell, M. (1995).
    
    Surveillance for arboviruses in mosquitoes in New South Wales, Australia, 1991/92-1994/95.
    
    Arthropod-Borne Virus Information Exchange, June 1995: 33-36.
17. RUSSELL, R.C. (1994).
    
    Ross River virus: disease trends and vector ecology in Australia.
    
    Bulletin of the Society for Vector Ecology, 19: 73-81.
18. RUSSELL, R.C., Doggett, S.L., Munro, R., Ellis, J., Avery, D., Hunt, C., and Dickeson, D. (1994).
    
    Lyme disease: A search for a causative agent in ticks in southeastern Australia.
    
    Epidemiology and Infection, 112: 375-384.
19. Wells, P.J., Cloonan, M.J. and RUSSELL, R.C. (1994).
    
    A pump system for collecting mosquito larvae from shallow ground pools (Diptera: Culicidae).
    
    Journal of the Australian Entomological Society, 33: 16.
20. Wells, P.J., RUSSELL, R.C., Cloonan, M.J., Hueston, L. and Geary, M.J. (1994).
    
    Virus infection and vector competence of Aedes alternans (Westwood) (Diptera: Culicidae) for Ross River virus.
    
    Journal of the Australian Entomological Society, 33: 373-375.
21. Wells, P.J., Vale, T.G., RUSSELL, R.C. and Cloonan, M.J. (1994).
    
    Comparison of a pledget technique with other methods for bloodfeeding mosquitoes (Diptera: Culicidae) for virus studies.
    
    Journal of the Australian Entomological Society, 33: 211-212.
22. Mackenzie, J.S. et al. (including RUSSELL, R.C.) (1993).
    
    Diagnosis and reporting of arbovirus infections in Australia.
    
    Communicable Diseases Intelligence, 17 (10): 202-206.
23. RUSSELL, R.C. (1993).
    
    Vector-borne diseases and their control.
    
    in B.P.Mulhall and G.V.Brown (Editors), 'Tropical Health'. Medical Journal of Australia, 158: 681-690.
24. RUSSELL, R.C. (1993).
    
    The search for Lyme borrelia in Australia.
    
    Chinese Journal of Pest Control, 9: 242-247.
25. RUSSELL, R.C., Doggett, S.L. and Munro, R. (1993).
    
    Tick ecology and the search for a possible Lyme disease spirochaete in southeastern Australia.
    
    Bulletin of the Society for Vector Ecology, 18: 77-84.
26. Scholz, A., RUSSELL R. and Geary, M. (1993).
    
    Investigation of caterpillar dermatitis in school children.
    
    NSW Public Health Bulletin, 4 (6): 65-66.
27. Linley, J.R., Geary, M.J. and RUSSELL, R.C. (1992).
    
    The eggs of Aedes vigilax and Aedes vittiger (Diptera: Culicidae).
    
    Proceedings of the Entomological Society of Washington, 94 : 48-58.
28. Linley, J.R., Geary, M.J. and RUSSELL R.C. (1992).
    
    The eggs of Aedes australis and Aedes camptorhynchus (Diptera: Culicidae).
    
    Mosquito Systematics, 24: 29-39.
29. RUSSELL, R.C. and Geary, M.J. (1992).
    
    The susceptibility of the mosquitoes Aedes notoscriptus and Culex annulirostris to infection with dog heartworm Dirofilaria immitis and their vector efficiency.
    
    Medical and Veterinary Entomology, 6: 154-58.
30. RUSSELL, R.C., Vale, T.G., Wells, P.J. and Cloonan, M.J. (1992).
    
    Monthly periodicity and abundance of mosquitoes (Diptera: Culicidae) near Batemans Bay on the south coast of New South Wales, 1985-1988.
    
    Journal of the Australian Entomological Society, 31: 281-88.
31. Linley, J.R., Geary, M.J. and RUSSELL, R.C. (1991).
    
    The eggs of Aedes funereus, Aedes notoscriptus and Aedes alternans (Diptera: Culicidae).
    
    Proceedings of the Entomological Society of Washington, 93: 592-612.
32. Linley, J.R., Geary, M.J. and RUSSELL, R.C. (1991).
    
    The eggs of Aedes (Finlaya) alboannulatus and Aedes (Finlaya) rubrithorax (Diptera: Culicidae).
    
    Mosquito Systematics, 23: 132-143.
33. Linley, J.R., Geary, M.J. and RUSSELL, R.C. (1991).
    
    Fine structure of the eggs of Aedes (Ochlerotatus) theobaldi, Ae. (Och.) sagax and Ae. (Och.) procax (Diptera: Culicidae).
    
    Mosquito Systematics, 23: 144-59.
34. RUSSELL, R.C. (1991).
    
    Arbovirus surveillance, New South Wales, 1989-91.
    
    Communicable Diseases Intelligence, 15 (14): 229-32.
35. RUSSELL, R.C. (1991).
    
    Arbovirus surveillance in N.S.W., Australia, 1989-91.
    
    Arthropod-Borne Virus Information Exchange, December 1991: 40-44.
36. RUSSELL, R.C. (1991).
    
    Scrub itch - bites in the bush.
    
    National Parks Journal, 35 (4): 16- 17.
37. RUSSELL, R.C., Cloonan, M.J., Wells, P.J. and Vale, T.G. (1991).
    
    Mosquito (Diptera: Culicidae) and arbovirus activity on the south coast of New South Wales, Australia, in 1985-1988.
    
    Journal of Medical Entomology, 28: 796-804.
38. RUSSELL, R.C. (1990).
    
    The relative importance of various mosquitoes for the transmission and control of dog heartworm in south-eastern Australia.
    
    Australian Veterinary Journal, 67: 191-192.
39. RUSSELL, R.C. (1990).
    
    Salt-marsh mosquitoes on the south coast of N.S.W.
    
    Bulletin of the Mosquito Control Association of Australia, 2: 6-11.
40. RUSSELL, R.C. (1990).
    
    Arbovirus/vector monitoring in N.S.W., Australia; 1988/89, 1989/90.
    
    Arthropod-Borne Virus Information Exchange, December 1990: 41-42.

PUBLISHED CONFERENCE PAPERS

1. Clancy, J.G. and RUSSELL, R.C. (1997).
   
   The "other" mosquitoes of New South Wales.
   
   Arbovirus Research in Australia, 7: 41-46.
2. Doggett, S.L., Koevski, I., Haniotis, J. and RUSSELL, R.C. (1997).
   
   MOSAVEX: a mechanical device to grind mosquitoes for arbovirus detection.
   
   Arbovirus Research in Australia, 7: 75-78.
3. Doggett, S.L. and RUSSELL, R.C. (1997).
   
   Aedes notoscriptus can transmit inland and coastal isolates of Ross River and Barmah Forest virus from NSW!
   
   Arbovirus Research in Australia, 7: 79-81.
4. Haniotis, J., Doggett, S.L., Cloonan, M.J. and RUSSELL, R.C. (1997).
   
   A quality control procedure for a fixed-cell ELISA.
   
   Arbovirus Research in Australia, 7: 88-91.
5. RUSSELL, R.C., Cloonan, M.J., Doggett, S.L., Clancy, J., Haniotis, J., Wells, P., Fennell, M., Cunningham, A., Hueston, L. and Marchetti, M. (1997).
   
   Surveillance of arboviruses and vectors in NSW, 1993-1996.
   
   Arbovirus Research in Australia, 7: 228-234.
6. RUSSELL, R.C. (1997).
   
   Coastal development: Constructed wetlands and mosquito management.
   
   7th Annual New South Wales Coastal Conference, Ballina, N.S.W., 12-14th November 1997: 144-151.
7. RUSSELL, R.C., Doggett, S.L., Clancy, J., Haniotis, J. and Cloonan, M.J. (1997).
   
   Mosquitoes and Barmah Forest virus: the 1995 epidemic in NSW.
   
   Arbovirus Research in Australia, 7: 235-239.
8. RUSSELL, R.C. and Geary, M.J. (1997).
   
   Which mosquitoes are the "best" vectors of dog heartworm?
   
   Arbovirus Research in Australia, 7: 243-246.
9. Webb, C. and RUSSELL, R.C. (1997).
   
   Investigation of the mosquito fauna and larval habitats of the saline wetlands at the Olympic site, Homebush Bay, Sydney.
   
   Arbovirus Research in Australia, 7: 308-310.
10. Wells, P., Mikunda, A., Doggett, S.L., Cloonan, M.J., RUSSELL, R.C., Weir, R.C., Marshall, I.D. and Dalgarno, L. (1997).
    
    Studies of the infectivity of selected strains of Ross River virus in Aedes vigilax and Culex annulirostris mosquitoes collected at coastal and inland sites of New South Wales.
    
    Arbovirus Research in Australia, 7: 322-325.
11. Willems, K. and RUSSELL, R.C. (1997).
    
    Freshwater mosquito control for the 2000 Olympics.
    
    Arbovirus Research in Australia, 7: 357-358.
12. RUSSELL, R.C. (1996).
    
    Mosquitoes and wastewater wetlands - enhancing natural cycles of zoonotic diseases?
    
    Pp 68-80 in Workshop on "Wetland Systems for Wastewater Treatment", 25 September 1996, Murdoch University, Perth, WA.
13. RUSSELL, R.C. (1995).
    
    Artificial wetlands and the mosquito/disease threat in southeastern Australia.
    
    in B.H.Kay (Ed.) Water resources: health, environment and development. Proceedings of conference, 26-28 April 1995, Townsville, Qld.
14. RUSSELL, R.C. and DOGGETT, S.L. (1995).
    
    Ticks and human disease in Australia - an update.
    
    in L.B.Coons (Ed.) Proceedings Second International Conference on Tick-borne Pathogens at the Host-Vector Interface, 28 August - 1 Sept, 1995, Kruger National Park, South Africa
15. RUSSELL, R.C. and Kuginis, L. (1995).
    
    Constructed wetlands and mosquitoes - some problems and some solutions.
    
    Pp 213-224 in Proceedings of the National Conference on 'Wetlands For Water Quality Control'. 25-29 September 1995, Townsville, Qld.
16. RUSSELL, R.C. (1994).
    
    Ross River virus - disease trends and vector ecology in Australia.
    
    Bulletin of the Society for Vector Ecology. 19: 73-81. Proceedings of the First International Congress of Vector Ecology, 2-8 October 1993, San Diego, U.S.A.
17. RUSSELL, R.C. (1994).
    
    Wetlands and mosquitoes - the pest and disease threats.
    
    Pp 45-51 in "Practical Aspects of Constructed Wetlands", Proceedings of a Workshop at Shortland Wetland Centre, Newcastle West. N.S.W. Department of Water Resources, June 1994, Newcastle, Australia.
18. RUSSELL, R.C., Doggett, S.L., Munro, R., Dickeson, D.J., Ellis, J., Avery, D. and Hunt, C. (1994).
    
    Lyme disease in Australia - reasonable doubt?
    
    Pp 212-215. in R.Cevenini, V.Sambri and M.LaPlaca (Eds). Proceedings of the VI International Conference on Lyme Borreliosis, 19-22 June 1994, Bologna, Italy.
19. RUSSELL, R.C. (1993).
    
    The search for Lyme borrelia in Australia.
    
    Chinese Journal of Pest Control. 9: 242-247. Proceedings of the International Vector Ecology Conference, 14 July 1992, Hainan, China.
20. RUSSELL, R.C. (1993).
    
    Requirements and problems for control of some arthropod pests of medical importance in urban Australia.
    
    Pp 113-116 in Proceedings International Conference on Insect Pests in the Urban Environment, 30 June - 3rd July 1993, Cambridge, U.K.
21. RUSSELL, R.C., Doggett, S.L. and Munro, R. (1993).
    
    Tick ecology and the search for a possible Lyme disease spirochaete in southeastern Australia.
    
    Bulletin of the Society for Vector Ecology. 18: 77-84. Proceedings of the VII European Meeting of the Society for Vector Ecology, 25-28 August 1992, Bologna, Italy.
22. Clancy, J.G. and RUSSELL, R.C. (1992).
    
    Further investigations into the influence of temperature on populations of Culex annulirostris Skuse (Diptera: Culicidae) in New South Wales.
    
    Arbovirus Research in Australia, 6: 5-10.
23. Doggett, S.L., RUSSELL, R.C., Munro, R., Dickeson, D., Ellis, J., Avery, D., Hunt, C., Simmons, J. and Trivett, N. (1992).
    
    Lyme disease - the search for the causative agent in southeastern Australia.
    
    Arbovirus Research in Australia, 6: 313-315.
24. Mackenzie, J.S., Broom, A.K., Calisher, C.H., Cloonan, M.J., Cunningham, A.L., Gibson, C.A., Hueston, L., Lindsay, M.D., Marshall, I.D., Phillips, D.A., RUSSELL, R.C., Sheridan, J., Smith, D.W., Smythe, L., Vitarana, T. and Worswick, D. (1992).
    
    Diagnosis and reporting of arbovirus infections in Australia.
    
    Arbovirus Research in Australia, 6: 89-93.
25. McManus, T.J., RUSSELL, R.C., Wells, P.J., Clancy, J.G., Fennell, M. and Cloonan, M.J. (1992).
    
    Further studies on the epidemiology and effects of Ross River virus in Tasmania.
    
    Arbovirus Research in Australia, 6: 68-72.
26. RUSSELL, R.C., Doggett, S., Dickeson, D., Hunt, C. and Munro R. (1992).
    
    Lyme disease and Australia - the current situation.
    
    Pp 265-79. in The Proceedings of the Australian Tropical Health and Nutrition Conference, 4-6 Nov 1991, Brisbane.
27. RUSSELL, R.C., Wells, P.J., Clancy, J.G., Naim, H.N., Marchetti, M., Fennell, M., Hueston, L., Cloonan, M.J., Hawkes, R.A. and Cunningham, A.L. (1992).
    
    The surveillance of arbovirus activity in N.S.W. 1989-1992.
    
    Arbovirus Research in Australia, 6: 76-80.
28. Wells, P.J., RUSSELL, R.C. and Cloonan, M.J. (1992).
    
    Investigating vector competence of Culex annulirostris and Aedes vigilax for Ross River virus and other alpha- and bunyaviruses.
    
    Arbovirus Research in Australia, 6: 10-14.
29. Wells, P.J., RUSSELL, R.C., Cloonan, M.J., Hueston, L. and Geary, M.J. (1992).
    
    Vector competence of Aedes alternans for Ross River virus.
    
    Arbovirus Research in Australia, 6: 320.
30. RUSSELL, R.C. (1991).
    
    Requirements and procedures for aircraft disinsection in the Asia-Pacific region.
    
    Pp 266-70, in Proceedings of the First Asia-Pacific Conference of Entomology, November 8-13 1989, Chiang Mai, Thailand.
31. RUSSELL, R.C. (1991).
    
    Introduced vector borne diseases in the Pacific.
    
    in Micronesica Supplement 3 : 33-39. The Proceedings of the Pacific Science Association Scientific Committee for Entomology Workshop on Exotic Pests in the Pacific - Problems and Solutions'. May 31- June 1, 1990, Guam.
32. RUSSELL, R.C. (1991).
    
    Arbovirus activity in southeastern Australia.
    
    in Bulletin of the Society for Vector Ecology, 16 : 222-26. Proceedings of the 22nd Annual Conference of the Society for Vector Ecology, 10-14 November, 1990, Mesa, Arizona, USA.
33. RUSSELL, R.C. (1991).
    
    The Lyme disease situation in Australia.
    
    in Bulletin of the Society for Vector Ecology, 16 : 227-29. Proceedings of the 22nd Annual Conference of the Society for Vector Ecology, 10-14 November, 1990, Mesa, Arizona, USA

SINTCHENKO

1. Sintchenko V & E.Coiera.
   
   Developing decision support systems in clinical bioinformatics.
   
   Methods of Molecular Medicine 2008;141:331-51.
2. Sintchenko V, Iredell JR, Gilbert GL.
   
   Genomic profiling of pathogens for disease management and surveillance.
   
   Nature Microbiology Reviews 2007;5:464-70.
3. Sintchenko V, Mitchell B, Gilbert GL.
   
   Is Bordetella pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971-2006.
   
   Journal of Antimicrobial Chemotherapy 2007;60(5):1178-9.
4. Cai Y, Kong F, Wang Q, Tong Z, Sintchenko V, Zeng X, Gilbert GL.
   
   Comparison of single and multilocus sequence typing and toxin gene profiling for characterisation of methicillin resistant Staphylococcus aureus (MRSA).
   
   Journal of Clinical Microbiology 2007;45(10):3302-8.
5. Sintchenko V. Magrabi F, Tipper S.
   
   Are we measuring the right thing? Variables that affect the impact of computerized decision support on patient outcomes: A systematic review.
   
   Medical Informatics and The Internet in Medicine 2007;32(3):225-40.
6. Dwyer DE, Sintchenko V.
   
   Point of care testing for community-acquired pneumonia: do we have all the answers?
   
   Medical Journal of Australia 2007; 187:40-42.
7. Coiera E, Magrabi F, Sintchenko V, Zrimec T, McDonnell G, Chung G, Tsafnat G.
   
   The Centre for Health Informatics at the University of New South Wales – a clinical informatics research centre.
   
   Methods of Information in Medicine 2007 46 Suppl.1: IMIA Yearbook of Medical Informatics; 159-166.
8. Merritt TD, Sintchenko V, Jelfs P, Worthing M, Robinson B, Durrheim DN, Gilbert GL.
   
   Outbreak of pulmonary tuberculosis in young Australians.
   
   Medical Journal of Australia 2007;186:240-242.
9. Sintchenko V, Gilbert GL.
   
   Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: A decision analysis.
   
   Tuberculosis 2007; 87:176-184.
10. Sintchenko V, Usherwood T, Coiera E.
    
    Are clinicians’ information needs and decision support affected by different models of care? Experimental study.
    
    MEDINFO 2007/ 12th World Congress on Health Informatics. Brisbane, August 2007. Kuhn K et al (Eds) IOS Press, 2007. PP895-899.
11. Sintchenko V, Coiera E.
    
    Decision complexity affects the extent and type of decision support use. In: Bates D (Ed). Proceedings of the Annual Scientific Meeting of American Medical Informatics Association. Washington DC, 11-15 Nov 2006.
    
    AMIA, 2006. PP.724-728.
12. Sintchenko V.
    
    Information processing in clinical decision-making.
    
    In: Lazakidou D (Ed). Handbook of Research on Informatics in Healthcare & Biomedicine. Idea Group, 2006. PP.147-153.
13. Sintchenko V, Jelfs P, Dally M, Crighton T, Gilbert GL.
    
    A case of urinary tuberculosis due to Mycobacterium bovis subsp. caprae.
    
    Pathology 2006;38(4):376-378.
14. Jelfs P, Sintchenko V, Gilbert GL.
    
    Genotyping of Mycobacterium tuberculosis in New South Wales: Results from 18 months of statewide trial.
    
    NSW Public Health Bulletin 2006;17(5-6):81-85.
15. Iredell JR, Sintchenko V.
    
    Screening for antibiotic resistant gram-negative bacteria (Communication).
    
    Lancet Infectious Diseases 2006;6:316-317.
16. Sintchenko V, Persson L, Lanser J.
    
    Communicable disease informatics – Emerging concepts in disease surveillance.
    
    In: Westbrook J & Callen J (Eds). Bridging digital divide: Clinician, consumer and computer/Proceedings of the 14th National Health Informatics Conference. Sydney, 20-22 Aug 2006. HISA, Melbourne. PP.30-35.
17. Sintchenko V, Iredell JR, Gilbert GL, Coiera E.
    
    Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.
    
    Journal of American Medical Informatics Association 2005;12:398-402.
18. Sintchenko V, Coiera E, Iredell J, Gilbert GL.
    
    The impact of decision support on antibiotic prescribing decisions: an interactive web experiment.
    
    Journal of American Medical Informatics Association 2004;11:71-77.
19. Sintchenko V, Coiera E.
    
    Which clinical decisions benefit from automation? A task complexity approach.
    
    International Journal of Medical Informatics 2003;70:309-316.

SORRELL

1. Sorrell TC, Forbes IJ, Burness FR, Rischbieth RHC.
   
   Depression of Immunological Function in Patients Treated with Phenytoin Sodium (Sodium Diphenylhydantoin).
   
   Lancet ii: 1971;1233-1235
2. Sorrell TC, Forbes IJ.
   
   Depression of Immune Competence by Phenytoin and Carbamazepine. Studies in vivo and in vitro.
   
   Clin. and Exp. Immunol. 1975;20: 273-285.
3. Sorrell TC, Forbes IJ.
   
   Phenytoin Sensitivity in a Case of Phenytoin-Associated Hodgkin's Disease.
   
   Aust. N.Z.J. Med. 1975;5: 144-147.
4. Sorrell TC, Forbes IJ.
   
   Phenytoin sodium - an interesting drug.
   
   South Aust. Clin., 1976;7: 127-139.
5. Sorrell TC, Lehrer RI, Cline MJ.
   
   Mechanism of Non-specific Macrophage-mediated Cytotoxicity. Evidence for Lack of Dependence Upon Oxygen.
   
   J. Immunol. 1978; 120: 347-352.
6. Chow AW, Carlson C, Sorrell TC.
   
   Host Defenses in Acute Pelvic Inflammatory Disease. Bacterial clearance in the murine uterus and oviduct.
   
   Am. J. Obstet. Gynecol. 1980;138: 1003-1005.
7. Lehrer RI, Ferrari LG, Paterson-Delafield J, Sorrell TC.
   
   Fungicidal Activity of Rabbit Alveolar and Peritoneal Macrophages Against Candida albicans.
   
   Infect. Immun. 1980; 28: 1001-1008.
8. Packham DR, Sorrell TC.
   
   Pneumonia with bacteraemia due to Escherichia coli.
   
   Aust. N.Z.J. Med. 1981;11: 669-672.
9. Shanker S, Daley DA, Sorrell TC.
   
   A Rapid Slide Co-agglutination Test - An Alternative to the Fluorescent Antibody Test for the Identification of Neisseria gonorrhoea.
   
   J. Clin. Path. 1981;34: 420-423.
10. Sorrell TC, Marshall JR, Chow AW.
    
    Antimicrobial Therapy of Post-partum Endomyometritis. 1. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria.
    
    Am. J. Obstet. Gynecol. 1981;141: 242-245.
11. Sorrell TC, Marshall JR, Yoshimori R, Chow AW.
    
    Antimicrobial therapy of Post-partum Endomyometritis. 2. Prospective, randomized trial of mezlocillin versus ampicillin.
    
    Am. J. Obstet. Gynecol. 1981;141: 246-251.
12. Sorrell TC, Packham DR, Helprin G, Munro R, Gibson JS.
    
    Staphylococcal toxic shock syndrome.
    
    Aust. N.Z.J. Obstet. Gynecol. 1981;21: 248-251.
13. Marshall JR, Chow AW, Sorrell TC.
    
    Effectiveness of mezlocillin in female genital tract infections.
    
    J. Antimicrob. Agents Chemother. 1982;9, Suppl. A: 149-158.
14. Shanker S, Rosenfield JA, Davey GR, Sorrell TC.
    
    Campylobacter jejuni: Incidence in processed broilers and biotype distribution in human and broiler isolates.
    
    Appl. and Environ. Microbiol. 1982;43: 1219-1220.
15. Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R.
    
    Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    
    Ann. Intern. Med. 1982;97: 344-350.
16. Collignon PJ, Sorrell TC.
    
    Disseminated candidiasis : evidence of a distinctive syndrome in heroin abusers.
    
    Brit. Med. J. 1983;287: 861-862.
17. Collignon PJ, Sorrell TC.
    
    Neurological toxicity associated with vidarabine therapy.
    
    Aust. N.Z.J. Med. 1983;13: 627-629.
18. Foldes M, Munro R, Sorrell TC, Shanker S, Toohey M.
    
    In vitro effects of vancomycin, rifampicin,and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcu aureus.
    
    J. Antimicrob. Chemother. 1983;11: 21-26.
19. Shanker S, Sorrell TC.
    
    Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents.
    
    Pathology 15: 1983;61-63.
20. Sorrell TC, Baker PA, Chow AW.
    
    Host Defenses in the upper genital tract of the female : studies in a murine system.
    
    Aust. J. Exp. Biol. Med. Sci. 1983;61: 287-299.
21. Collignon PJ, Munro R, Sorrell TC.
    
    Systemic sepsis and intravenous devices. A prospective survey.
    
    Med. J. Aust. 1984;141: 345-348.
22. Gruenewald SM, Collignon PJ, Crocker EF, Sorrell TC.
    
    Increased renal uptake of Tc-99m MDP in amphotericin B nephrotoxicity.
    
    Noninvasive Med. Imaging. An Internat. J. 1984;1:179-183.
23. Marcus AJ, Safier LB, Broekman MJ, Islam N, Sorrell TC, Serhan CN, Weissman G, Oglesby TD, Gorman RR.
    
    Production of metabolic products of arachidonic acid during cell-cell interactions.
    
    J. Allergy and Appl. Immunol. 1984;74: 338-341.
24. Munro R, Collignon PJ, Sorrell TC, Tomlinson P.
    
    Is the Antibiotic Removal Device (ARD) a cost-effective addition to conventional blood cultures ?
    
    J. Clin. Path. 1984;37: 348-51.
25. Sorrell TC, Dunlop C, Collignon PJ, Harding JA.
    
    Exogenous ocular candidiasis associated with intravenous heroin abuse.
    
    Brit. J. Ophthalmol. 1984;168: 841-845.
26. Blackie JD, Danta G, Sorrell T, Collignon P.
    
    Ophthalmological complications of cryptococcal meningitis.
    
    Clin and Exp. Neurol. 1985;21: 263-270.
27. Collignon PJ, Sorrell TC, Uther JB.
    
    Prevention of sepsis associated with the insertion of intravenous cannulae. The experience in a coronary care unit
    
    Med. J. Aust. 1985;142: 346-348.
28. Müller M, Sorrell TC.
    
    Quantitation of sulfidopeptide leukotrienes by reverse phase high-performance liquid chromatography.
    
    J. Chromatog. 1985;343: 213-218.
29. Sorrell TC, Lehrer RI, Ferrari LG, Müller M, Selsted ME.
    
    Divergent expression of cytotoxic and microbicidal functions of rabbit alveolar and peritoneal macrophages : effects of nonspecific activation and a natural microbicidal peptide, MCP-1.
    
    Aust. J. Exp. Biol. Med. Sci. 1985;63: 53-63.
30. Sorrell TC, Collignon PJ.
    
    A prospective study of adverse reactions associated with vancomycin therapy.
    
    J. Antimicrob. Chemother. 1985;16: 235-241.
31. Collignon PJ, Sorrell TC, Garret P.
    
    Unsuccessful search for anaerobic bacteria in thrombophlebitis associated with peripheral venous catheters.
    
    Letter, New Eng. J. Med. 1986;314: 1323.
32. Collignon PJ, Munro R, Sorrell TC.
    
    Propionibacterium acnes infection in neurosurgical patients. Experience with high-dose penicillin therapy.
    
    Med. J. Aust. 1986;145: 408-410.
33. Collignon PJ, Soni N, Pearson IY, Woods WP, Sorrell TC, Munro R.
    
    Semiquantitative culture of central vein catheters : is it useful in the diagnosis of catheter-associated bacteremia?
    
    J. Clin. Micro. 1986;24: 532-535.
34. Dwyer DE, Packham DR, Sorrell TC.
    
    Aspiration drainage of splenic abscesses.
    
    Aust. N.Z. J. Surg. 1986;56: 689-692.
35. Munro R, Sorrell TC.
    
    Biliary census - A review of treatment options.
    
    Drugs 1986;31: 449-454.
36. Shanker S, Lee A, Sorrell TC.
    
    Campylobacter jejuni in broilers: the role of vertical transmission.
    
    J. Hyg., Camb. 1986;96: 153-159.
37. Collignon PJ, Sorrell TC.
    
    Systemic candidiasis in heroin addicts (Letter).
    
    J. Infect. Dis. 1987;155: 595.
38. Dwyer DE, Collignon PJ, MacLeod C, Sorrell TC.
    
    Extrapulmonary tuberculosis -a continuing problem in Australia.
    
    Aust. N.Z. J. Med. 1987;17: 507-511.
39. Collignon P, Sorrell T, and Garret P.
    
    Are anaerobic bacteria involved in peripheral vein catheter associated thrombophlebitis?
    
    Biomed. & Pharmacother., 1988;42: 213-215.
40. Collignon PJ, Soni N, Pearson I, Sorrell TC, Woods P.
    
    Sepsis associated with central vein catheters in critically ill patients.
    
    Intensive Care Med., 1988;14: 227-231.
41. Rawlinson WD, Sorrell TC, Dwyer D, Munro R.
    
    Bacteremia in neutropenic patients at a major teaching hospital 1981-1987.
    
    Aust. N.Z. J. Med. 1988;18: 815-817.
42. Shanker S, Lee A, Sorrell TC.
    
    Experimental colonization of broiler chicks with Campylobacter jejuni.
    
    Epidemiol. Infect (formerly J. Hygiene) 1988;100: 27-34.
43. Shanker S, Lee A, Sorrell TC.
    
    Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies.
    
    Epidemiol. Infect. 1990;104: 101-110.
44. Sorrell TC, Rochester CP, Breen FN, Müller M.
    
    Eicosanoids produced during interactions between Pseudomonas aeruginosa and alveolar macrophages are species-dependent.
    
    Immunol. Cell. Biol. 1989;67: 169-176.
45. Lieschke G, Bell D, Rawlinson W, Green MD, Sheridan W, Morstyn G, Stuart-Harris R, Kefford RF, Levi J, Sorrell TC, Fox R.
    
    Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients.
    
    An overview. Europ. J. Cancer Clin. Oncol. 1989;24: 537-542.
46. Chen SC, Sorrell TC, Dwyer DE, Collignon PJ, Wright EJ.
    
    Endocarditis associated with prosthetic cardiac valves.
    
    Med. J. Aust. 1990;152: 458-463.
47. Roger SD, Chen SCA, Lawrence S, Sorrell TC.
    
    Pseudomonas putrefaciens bacteraemia in a peritoneal dialysis patient.
    
    Letter. Nephrol. Dial. Transplant. 1991;6:73.
48. May GL, Sztelma K, Sorrell TC, and Mountford CE.
    
    Comparison of human polymorphonuclear leukocytes from peripheral blood and purulent exudates by high resolution 1H MRS.
    
    Mag. Res. Med. 1991;19: 191-198.
49. Chen SCA, Lawrence RH, Packham DR, Sorrell TC.
    
    Cellulitis due to Pseudomonas putrefaciens.
    
    Case Report. Rev. Infect. Dis. 1991;13: 642-643.
50. Fletcher JP, Dryden M, and Sorrell TC.
    
    1991. Infection of vascular prostheses.
    
    Aust. N.Z. J. Surg. 1991;61: 432-435.
51. Muller M, Sorrell TC.
    
    Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives.
    
    Infect. Immun. 1991;59: 3316-3318.
52. Muller M, Sorrell TC.
    
    Effect of pyocyanin and 1-hydroxyphenazine on the assay of lactate dehydrogenase activity.
    
    J. Infect. Dis. 1991;164: 610-611.
53. Foley P, Kazazi F, Biti R, Sorrell TC, Cunningham AL.
    
    HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids.
    
    Immunology 1992;75: 391-397.
54. Mitchell DH, Sorrell TC.
    
    Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans var. gattii.
    
    Clin Infect Dis, 1992;14: 1142-1144.
55. Kazazi F, Mathijs JM, Chang J, Malafiej P, Lopez A, Downton D, Sorrell TC, Vadas MA, Cunningham AL.
    
    Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages.
    
    J. Gen. Virol 1992;73: 941-949.
56. May GL, Dunlop LC, Sztelma K, Berndt MC and Sorrell TC.
    
    GMP-140 (P-Selectin) inhibits human neutrophil activation by lipopolysaccharide: analysis by proton magnetic resonance spectroscopy.
    
    Biochem. Biophys. Res. Comm., 1992;183: 1062-1069.
57. Sorrell TC, Muller M, Sztelma K.
    
    Bacterial metabolism of human polymorphonuclear leukocyte-derived arachidonic acid.
    
    Infect. Immun. 1992;60: 1779-1785.
58. Muller M, Sorrell TC.
    
    Leukotriene B4 -oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa.
    
    Infect. Immun. 1992;60: 2536-2540.
59. Lawrence RH, Sorrell TC.
    
    Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
    
    Clin. Exp. Immunol. 1992;89: 321-324.
60. Chen SCA, Dwyer DE, Sorrell TC.
    
    A comparison of hospital and community-acquired endocarditis.
    
    Am. J. Cardiol. 1992;70: 1449-1452.
61. Lawrence RH, Sorrell TC.
    
    Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenic role for leukotriene B4.
    
    Lancet 1993;342: 465-469.
62. May GL, Sztelma K, Paul ML, Sorrell TC.
    
    Proton magnetic resonance spectroscopy of polymorphonuclear leukocytes from patients with serious bacterial infections.
    
    J. Infect. Dis. 1993;168: 386-392.
63. Chen SCA, Lawrence RH, Byth K, Sorrell TC.
    
    Pseudomonas aeruginosa bacteremia: is pancreatobiliary disease a risk factor?
    
    Med. J. Aust. 1993;159: 592-597.
64. Holland D, Sorrell TC.
    
    Antimicrobial therapy and prevention of spontaneous bacterial peritonitis.
    
    J Gastroentol Hepatol. 1993;8: 370-375.
65. May GL, Sztelma K, Sorrell TC.
    
    The presence of cytoplasmic lipid droplets is not sufficient to account for neutral lipid signals in the 1H MR spectra of neutrophils.
    
    Mag. Res. Med. 1994;31: 212-217.
66. Lawford R, Sorrell TC.
    
    Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity.
    
    Clin. Inf. Dis. 1994;19: 346-348.
67. Chew W, Sorrell TC, Gilbert GL.
    
    Subtyping of Mycobacterium avium complex (MAC) isolates by thin-layer chromatography - distribution of subtypes from patients with AIDS compared with clinically non-significant isolates.
    
    Epidemiol Infect. 1994;112: 543-549.
68. Sorrell TC, Sztelma K, May GL.
    
    Circulating polymorphonuclear leukocytes from patients with Gram-negative bacteremia are not primed for enhanced production of leukotriene B4 or 5-hydroxyeicosatetraenoic acid.
    
    J. Infect. Dis; 1994;169: 1151-1154.
69. Dwyer DE, Chen SCA, Wright EJ, Crimmins D, Collignon PJ, Sorrell TC.
    
    Hospital practices influence the pattern of infective endocarditis.
    
    Med J Aust; 1994;160: 709-718.
70. Lawrence RH, and Sorrell TC.
    
    Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis.
    
    Clin Exp Immunol., 1994;98: 12-16.
71. Muller M, Sztelma K, Sorrell TC.
    
    Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin.
    
    Ann. N.Y. Acad. Sci. 1994;744: 35-36.
72. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottlieb T.
    
    Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococccal variety on clinical manifestations and outcome.
    
    Clin.Infect. Dis. 1995;20: 611-616.
73. Chen SCA, Brownlee AG, Sorrell TC, Ruma P, Ellis DH, Pfeiffer J, Speed BR, Nimmo G.
    
    Identification by random amplification of polymorphic DNA (RAPD) of a common molecular type of C. neoformans var. neoformans in patients with AIDS and other immunosuppression.
    
    J. Infect. Dis. 1996; 173:754-758.
74. Sorrell TC, Chen SCA, Ruma P, Meyer W, Pfeiffer TJ, Ellis DH, Brownlee AG.
    
    Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA (RAPD) analysis and PCR fingerprinting.
    
    J. Clin. Microbiol. 1996; 34:1253-1260.
75. Sorrell TC, Brownlee AG, Ruma P, Malik R, Pfeiffer TJ, Ellis DH.
    
    Natural environmental sources of Cryptococcus neoformans var gattii.
    
    J. Clin. Microbiol. 1996; 34:1261-1263.
76. Müller M, Sorrell TC.
    
    Inhibition of the Human Platelet Cyclooxygenase Response by the Naturally Occurring Phenazine Derivative, 1-Hydroxyphenazine.
    
    Prostaglandins 1996;50: 301-311.
77. Ruma P, Chen SCA, Sorrell TC, Brownlee AG.
    
    Characterization of Cryptococcus neoformans by random DNA amplification.
    
    Lett. Appl. Microbiol. 1996; 23: 312-316.
78. Chen S, Müller M, Zhou JZ, Wright LC, Sorrell TC.
    
    Phospholipase activity in Cryptococcus neoformans: a new virulence factor?
    
    J. Infect. Dis. 1997; 175: 414-420.
79. Chen SCA, Wright LC, Müller M, Moran VR, Kuchel PW, Sorrell TC.
    
    Identification of phospholipase B, lysophospholipase and acyltransferase activities produced by Cryptococcus neoformans.
    
    Infect. Immun. 1997; 65: 405-411.
80. Müller M, Sorrell TC.
    
    Oxidative stress and the mobilisation of arachidonic acid in stimulated human platelets: role of hydroxyl radical. 1996.
    
    Prostaglandins 1997; 54: 493-510.
81. Wright LC, Nouri-Sorkhabi MH, May GL, Dankwerts L, Kuchel P, Sorrell TC.
    
    Changes in cellular and plasma membrane phospholipid composition in lipopolysaccharide-stimulated human neutrophils, studied by 31P NMR.
    
    European Journal of Biochemistry. 1997;243(1&2): 328-335.
82. Müller M, Sorrell TC.
    
    Modulation of the neutrophil superoxide response and intracellular diacylglycerol levels by the bacterial pigment, pyocyanin.
    
    Infect. Immun. 1997;65(6):2483-2487.
83. Chen SCA, Currie BJ, Campbell HM, Fisher D, Pfeiffer TJ, Ellis D, Sorrell TC.
    
    Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts.
    
    Trans. Roy. Soc. Med. 1997; 91: 547-550.
84. Meyer W, Latouche GN, Daniel H-M, Thanos M, Mitchell TG, Yarrow D, Schönian G, Sorrell TC.
    
    Identification of pathogenic yeasts of the imperfect genus Candida by PCR-fingerprinting.
    
    Electrophoresis 1997; 18: 1548-1559.
85. May GL, Wright LC, Groot-Obbink K, Byleveld PM, Garg ML, Ahmad ZI, Sorrell TC.
    
    Increased saturated triacyclglycerol levels in plasma membranes of human neutophils stimulated by lipopolysaccharide.
    
    J. Lipid Res. 1997; 38: 1562-1570.
86. Latouche GN, Daniel HM, Lee OC, Mitchell TG, Sorrell TC, Meyer W.
    
    Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species.
    
    J. Clin. Microbiol. 1997; 35: 3171-3180.
87. Santangelo RT, Nouri-Sorkhabi MH, Sorrell TC, Cagney M, Chen SCA, Kuchel PW, Wright LC:
    
    Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state.
    
    J. Med. Microbiol. 1999; 48:1-10.
88. Meyer W, Marszewska K, Amirmostofian M, Igreja RP, Hardke C, Methling K, Viviani MA, Chindamporn A, Sukroongreung S, John M-A, Ellis DH, Sorrell TC.
    
    Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by PCR-fingerprinting and RAPD - a pilot study to standardize techniques on which to base a detailed epidemiological survey.
    
    Electrophoresis. 1999; 20:1790-1799.
89. Bubb WA, Wright LC, Cagney M, Santangelo RT, Sorrell TC, Kuchel PW.
    
    Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors.
    
    Mag. Reson. Med. 42:442-453, 1999.
90. Wright LC, Groot Obbink K, Delikatney EJ, Santangelo RT, Sorrell TC.
    
    The origin of 1H NMR-visible triacylglycerol in human neutrophils: high fatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol.
    
    Eur. J. Biochem. 267: 68-78, 2000.
91. Chen SCA, Wright, LC, Golding, JC, Sorrell TC.
    
    Purification and characterisation of secretory phospholipase B, lysophospholipase and lysophospholipase-transacylase from a virulent strain of the pathogenic fungus, Cryptococcus neoformans.
    
    Biochem. J. 347:431-439, 2000.
92. Chen SCA, Sorrell TC, Nimmo GR, Speed B, Currie B, Ellis D, Marriott D, Pfeiffer T, Parr D, Byth K and the Australasian Cryptococcal Study Group.
    
    Epidemiology host and variety-dependent characteristics of infection in Australia and New Zealand due to Cryptococcus neoformans.
    
    Clinical Infectious Diseases. 31:499-508, 2000.
93. Ruma-Hayes P, Brownlee AG, Sorrell TC.
    
    A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates.
    
    J Med Microbiol. 49(8):733-7, 2000.
94. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM.
    
    Cryptococcosis: clinical and biological aspects.
    
    Med. Mycol. 38 Suppl 1:205-13, 2000.
95. Sorrell TC.
    
    Cryptococcus neoformans variety gattii. Invited review.
    
    Med Mycol. 39:155-68, 2001.
96. Cox GM, McDade HC, Chen SCA, Tucker S, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, Perfect JR.
    
    Phospholipase B is a virulence factor for Cryptococcus neoformans.
    
    Mol Microbiol. 39:166-75, 2001.
97. Meyer W, Maszewska K, Sorrell TC.
    
    PCR-fingerprinting, a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans.
    
    Med Mycol. 39:185-93, 2001.
98. Himmelreich U, Dzendrowskyj TE, Allen C, Dowd S, Malik R, Shehan BP, Russell P, Mountford CE, Sorrell TC.
    
    Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study.
    
    Radiology. 220:122-8, 2001.
99. Daniel HM, Sorrell TC, Meyer W.
    
    Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs.
    
    Int. J Syst. Evol. Microbiol. 51:1593-606, 2001.
100. Bourne R, Himmelreich U, Sharma A, Mountford C, Sorrell, T.
     
     Identification of Enterococcus, Streptococcus, and Staphylococcus by multivariate analysis of proton magnetic resonance spectroscopic data from plate cultures.
     
     J. Clin Microbiol. 39:2916-23, 2001.
101. Murray RJ, Himmelreich U, Gomes L, Ingham NJ, Sorrell TC.
     
     Cerebral nocardiosis characterized by Magnetic Resonance Spectroscopy in vivo.
     
     Clin Infect Dis. 34 (6) 849-52, 2002.
102. Wright LC, Chen SCA, Wilson CF, Simpanya MF, Blackstock R, Cox G. Murphy JW, Sorrell TC.
     
     Strain-dependent effects of environmental signals on the production of extracellular phospholipase by Cryptococcus neoformans.
     
     FEMS Microbiol. Lett. 209 (2):175-81, 2002.
103. Wright L, Bubb W, Davidson J, Santangelo R, Krockenberger M, Himmelreich U, Sorrell T.
     
     Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function.
     
     Microbes Infect. 4 (14):1247-38, 2002.
104. Latouche GN, Sorrell TC, Meyer W.
     
     Isolation and characterisation of the phospholipase B gene of C. neoformans var. gattii.
     
     FEMS Yeast Res. 2:551-61, 2002.
105. Latouche GN, Sorrell TC, Meyer W.
     
     PCR-restriction fragment length polymorphism analysis of the phospholipase B (plb1) gene for subtyping of Cryptococcus neoformans isolates.
     
     Appl. Environ. Microbiol. 69 (4) 2080-86, 2003.
106. Himmelreich U, Allen C, Dowd S, Malik R, Shehan BP, Mountford CM, Sorrell TC.
     
     Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcomas in rat lung using Magnetic Resonance Spectroscopy.
     
     Microbes Infect. 5:285-90, 2003.
107. Kidd S, Sorrell TC, Meyer W.
     
     Isolation of two molecular types of Cryptococcus neoformans from insect frass.
     
     Med. Mycol. 41: 171-176, 2003.
108. Himmelreich U, Somorjai RL, Dolenko B, Lee OC, Daniel H, Murray R, Mountford CE, Sorrell TC.
     
     Rapid identification and chemical characterization of Candida species using nuclear magnetic resonance spectroscopy and a statistical classification strategy.
     
     Appl. Environ. Microbiol. 69 (8): 4566-74, 2003.
109. Coe JGS, Wilson CF, Sorrell TC, Latouche NG, Wright LC.
     
     Cloning of CnLYSO1, a novel extracellular lipase of the pathogenic fungus Cryptococcus neoformans.
     
     Gene 316:67-68, 2003.
110. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L.
     
     The role of extracellular phospholipases and mononuclear phagocytes in the dissemination of cryptococcosis in a murine model.
     
     Infect Immun. 72:2229-2239, 2004.
111. Baumgartner R, Somorjai R, Bowen C, Sorrell TC, Mountford CE, Himmelreich U.
     
     Unsupervised feature dimension reduction for classification of MR spectra.
     
     Magn Reson Imag. 22:251-6, 2004.
112. Slavin MA, Szer J, Grigg AP, Roberts AW, Seymour JF, Sasadeusz J, Thurdky K, Chen SC, Morissey CO, Heath CH, Sorrell TC and the Mycoses Interest Group of the Australasian Society for Infectious Diseases.
     
     
     
     Int Med J 34:192-200, 2004.
113. Ganendren R, Widmer A, Singhal V, Wilson C, Sorrell T, Wright LC.
     
     In vitro antifungal activity of secretory and newly characterised cell-associated phospholipases from the fungal pathogen, Cryptococcus neoformans.
     
     Antimicrob. Agents Chemother. 48:1561-69, 2004.
114. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L.
     
     The role of extracellular phospholipases and mononuclear phagocytes in the dissemination of cryptococcosis in a murine model.
     
     Infect Immun. 72:2229-2239, 2004.
115. Playford EG, Webster AC, Sorrell TC, Craig JC.
     
     Antifungal agents for preventing fungal infections in solid organ transplant recipients (Cochrane review).
     
     In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
116. Chang YC, Wright LC, Tscharke RL, Sorrell TC, Wilson CF, Kwon-Chung KJ.
     
     Regulatory roles for the homeodomain and C2H2 zinc finger regions of Cryptococcus neoformans Ste12p.
     
     Mol Microbiol. 53:1385-96, 2004.
117. Wright LC, Payne J, Santangelo RT, Mukoma F, Chen SCA, Widmer F, Sorrell TC.
     
     A novel lysophospholipase discovered in the pathogenic fungus Cryptococcus gattii.
     
     Biochem J. 384:377-84, 2004.
118. Santangelo RT, Chen SC, Sorrell TC, Wright LC.
     
     Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA)
     
     Med Mycol. 43:335-41, 2005.
119. Himmelreich U, Accurso R, Malik R, Dolenko B, Somorjai RL, Gupta RK, Gomes L, Mountford CE, Sorrell TC.
     
     Rapid identification of Staphylococcus aureus brain abscesses by metabolite profiling using 1H Magnetic Resonance Spectroscopy.
     
     Radiology. 236:261-70, 2005.
120. Dzendrowskyj TE, Dolenko B, Sorrell TC, Somorjai RL, Malik R, Mountford CE and Himmelreich U:
     
     Identification of cerebral cryptococcoma using a computerised analysis of 1H NMR spectra in an animal model.
     
     Diagnostic Microbiol Infect Dis epub www.sciencedirect.com, 52:101-5, 2005.
121. Djordjevic J, del Poeta M, Sorrell TC, Wright LC.
     
     Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor.
     
     Biochem J. 2005; 389:803-12, 2005.
122. Halliday C, Wu Qi Xuan, James G, Sorrell TC.
     
     Development of a nested qualitative real-time PCR assay to detect Aspergillus DNA in clinical specimens.
     
     J Clin Microbiol, 43(10):5366-8, 2005.
123. Coen M, O’Sullivan M, Bubb WA, Kuchel PW, Sorrell T.
     
     1H NMR-based metabonomics for rapid diagnosis of meningitis and ventriculitis.
     
     Clin Infect Dis. 41(11):1582-90, 2005.
124. Himmelreich U, Somorjai RL, Dolenko B, Daniel H-M, Sorrell TC.
     
     A rapid screening test to distinguish between Candida albicans and Candida dubliniensis using NMR spectroscopy.
     
     FEMS Microbiol Lett, 15:251(2):327-32, 2005.
125. Playford EG, Kong F, Sun Y, Wang H, Halliday C, Sorrell TC.
     
     Simultaneous detection and identification of Candida, Aspergillus and Cryptococcus species by Reverse Line Blot (RLB) Hybridisation.
     
     J Clin Microbiol. 44:876-880, 2006.
126. Ganendren R, Carter E, Sorrell TC, Wright L.
     
     Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell lines.
     
     Microbes & Infection., 8(4):1006-15, 2006.
127. Halliday C, Hoile R, Sorrell TC, Janes G, Yadav S, Shaw P, Bleakley M, Bradstock K, Chen S.
     
     Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
     
     Br J Haem 132:478-486, 2006.
128. Widmer F, Wright LC, Obando D, Handke R, Ganendren R, Ellis DH, Sorrell TC.
     
     Hexadecylphosphocholine (Miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.
     
     Antimicrob. Agents Chemother. 50(2):414-421, 2006.
129. Ng CK, Obando D, Widmer F, Wright LC, Sorrell TC, Jolliffe KA.
     
     Correlation of antifungal activity with fungal phospholipase inhibition using a series of bisquaternary ammonium salts.
     
     J Med Chem. 49 (2):811-816, 2006.
130. Playford E, Webster A, Sorrell T, Craid J.
     
     Antifungal agents for preventing infections in non-neutropenic critically ill patients.
     
     Cochrane data base of systematic reviews: Jan 25;(1):CD004920, 2006.
131. Playford EG, Webster AC, Sorrell TC, Craig JC.
     
     Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients:systematic review and meta-analysis of randomised clinical trials.
     
     J Antimicrob Chemother57(4):628-38, 2006.
132. Sorrell TC, Wright LC, Malik R, Himmelreich U.
     
     Application of proton nuclear magnetic resonance spectroscopy to the study of Cryptococcus and cryptococcosis.
     
     FEMS Yeast Res. 6:558-566, 2006.
133. Playford EG, Webster AC, Sorrell TC, Craig JC.
     
     A systematic review of antifungal agents for preventing fungal infections in liver transplant recipients.
     
     European J Clin Microbiol Infect Dis 2006; 25(9):549-61, 2006.
134. Siafakis AR, Wright LC, Sorrell TC, Djordjevic JT.
     
     Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase.
     
     Eukaryotic Cell. 5:488-98, 2006.
135. Turner KM, Wright LC, Sorrell TC, Djordjevic JM.
     
     N-linked glycosylation sites affect secretion of cryptococcal phospholipase B1, irrespective of glycosylphosphatidylinositol anchoring.
     
     Biochim Biophys Acta (General Subjects) 1760(10):1569-79, 2006.
136. Chen SCA, Slavin M, Nguyen Q, Marriott D, Playford G, Ellis D, Sorrell T.
     
     National, population-based, active surveillance of candidamia in Australia with emphasis on disease acquired outside of hospitals.
     
     Emerging Infect Dis 12 (10):1508-16, 2006.
137. Coen M, Bodkin J, Power D, Bubb WA, Himmelreich U, Kuchel PW, Sorrell TC.
     
     Antifungal effects on metabolite profiles of medically important yeasts measured by nuclear magnetic resonance spectroscopy.
     
     Antimicrob Agents Chemother 50(12):4018-26, 2006.
138. Sorrell TC, Lonsdale C
     
     Urgent strategic research into influenza to inform health policy and protect the public.
     
     Med J Aust 185 (Suppl 10):S77-9, 2006.
139. Anaissie EJ, Segal BH, Graybill JR et al (incl. Sorrell TC).
     
     Clinical research in the lay press:irresponsible journalism raises a huge dose of doubt.
     
     Clin Infect Dis 43(8):103109, 2006.
140. Wu QX, Chen SCA, Santangelo RM, Martin P, Malik R, Sorrell TC.
     
     Cryptococcal phospholipase B antigen is not detected in serum of patients infected with Cryptococcus neoformans using a sandwich enzyme-linked immunosorbent assay (ELISA).
     
     FEMS Yeast Res 7(3):465-70, 2007.
141. Wright LC, Santangelo R, Ganendren R, Payne J, Djordjevic J, Sorrell TC.
     
     Cryptococcal lipid metabolism: phospholipase B1 is implicated in transcellular metabolism of macrophage-derived lipids.
     
     Eukaryotic Cell 6(1):37-47, 2007.
142. Lau A, Shen S, Sorrell T, Carter D, Malik R, Martin P, Halliday C.
     
     Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens.
     
     J Clin Microbiol 45(2):380-5, 2007.
143. Tong Z, Widmer F, Sorrell TC, Guze Z, Jolliffe KA, Halliday C, Lee OC, Kong F, Wright LC, Chen SC.
     
     In-vitro activity of miltefosine and two novel antifungal bis-cationic salts against a panel of 77 dermatophytes.
     
     Antimicrob Agents Chemother 51(6):2219-22, 2007.
144. Ng CK, Singhal V, Widmer F, Wright LC, Sorrell TC, Jolliffe KA.
     
     Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium) salts.
     
     Bioorg Med Chem 15(10):3422-9, 2007.
145. Obando D, Widmer F, Wright LC, Sorrell TC, Jolliffe KA.
     
     Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
     
     Bioorg Med Chem. 15(15):5158-65, 2007.
146. Jones P, Turner K, Djordjevic J, Sorrell T, Wright L, George A.
     
     Role of conserved active site residues in catalysis by phospholipase B1 from Cryptococcus neoformans.
     
     Biochemistry 46(35):10024-32, 2007; Epub 9/8/07.
147. Zeng X, Kong F, Halliday C, Chen S, Lau A, Playford G, Sorrell TC.
     
     Reverse line blot (RLB) hybridization assay for the identification of medically important fungi from culture and clinical specimens.
     
     J Clin Microbiol 45(9):2872-80, 2007. Epub 18/7/07.
148. Plummer R, Bodkin J, Yau TW, Power D, Pantarat N, Larkin TJ, Szekely D, Bubb WA, Sorrell TC, Kuchel PW.
     
     Modelling Staphylococcus aureus-induced septicemia using NMR.
     
     Magn Reson Med. 58(4):656-65, 2007.
149. Plummer R, Bodkin J, Power D, Pantarat N, Bubb WA, Kuchel PW, Sorrell TC.
     
     Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopy.
     
     Antimicrob Agents Chemother. 51 (11): 4077-4084, 2007
150. Siafakis AR, Sorrell TC, Wright LC, Wilson C, Larson M, Boadle R, Williamson PR, Djordjevic JT.
     
     Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity.
     
     J Biol Chem. 282 (52): 37508-14, 2007. Epub 18/10/07
151. Chen SCA, Tong Z, Lee OC, Halliday C, Playford EG, Widmer F, Kong F, Wu C, Sorrell TC.
     
     Clinician response to Candida organisms in the urine of patients attending hospital.
     
     Eur J Clin Microbiol Infect Dis. 4/12/07 E pub ahead of print. 27 (3):201-8, 2008.
152. Branley JM, Roy B, Dwyer DE, Sorrell T.
     
     Real Time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster.
     
     Eur J Clin Microbiol Infect Dis. 9/1/08. Epub ahead of print.
153. Kong F, Tong Z, Chen X, Sorrell T, Wang B, Wu X, Ellis D Chen S.
     
     Rapid identification and differentiation of Trichophyton species based on sequence polymorphisms of the ribosomal internal transcribed spacer regions by rolling circle amplification.
     
     J Clin Microbiol 46 (4) 1192-9, 2008.
154. Delhaes L, Harun A, Chen S, Slavin M, Heath C, Nguyen Q, Maszewska K, Halliday C, Robert V, Sorrell TC, the Australian Scedosporium (AUSCEDO) Study group, Meyer, W.
     
     Molecular typing of Australian Scedosporium isolates showing genetic variability and numeroius S. aurantiacum.
     
     Emerg Infect Dis, 14:282-90, 2008
155. Playford EG, Marriott D, Nguyen Q, Chen SCA, Ellis DH, Slavin M, Sorrell TC.
     
     Candidemia in non-neutropenic critically ill patients: risk factors for non-albicans Candida species.
     
     Accepted Crit Care Med. 2/3/08.
156. Chayakulkeree M, Sorrell TC, Siafakis AR, Wilson CF, Pantarat N, Gerik KJ, Boadle R, Djordjevic JT.
     
     Role and Mechanism of Phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans.
     
     Mol Microbiol Accepted 15/5/08.
157. Zhou X, Kong F, Sorrell TC, Wang H, Duan Y, Chen SCA.
     
     A practical method for detection and identification of Candida, Aspergillus and Scedosporium using rolling circle amplification (RCA).
     
     J Clin Microbiol..
158. Ngamskulrungro P, Sorrell TC, Chindamporn A, Chaiprasert A, Poonwan N, Meyer W.
     
     Association between fertility and molecular subtype of global isolates of Cryptococcus gattii molecular type VGII.
     
     Med Mycol. 46:1-9, 2008.
159. De Pauw B, Walsh TJ, Donnelly JP & 29 international authors including Sorrell TC.
     
     Revised definitions of Invasive Fungal Disease from the European Organisation for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study group (EORTC/MSG) Consensus Group.
     
     Clin Infect Dis. 46: (12):1813-21, 2008. TCS is a member of the MSG.
160. Ali M, Carter EA, Sorrell TC, Power D, Lay PA.
     
     Identification and differentiation of Aspergillus species using Fourier Transform Infrared Spectroscopy (FT-IR) and chemometrics.
     
     J Clin Microbiol Submitted
161. Himmelreich U, Malik R, Kuhn T, Somorjai RL, Dolenko B, Sorrell TC.
     
     Miniaturisation of diagnostic platforms – towards rapid etiological diagnosis of meningitis using micro-NMR spectroscopy and a statistical classification strategy.PLoS pathogens
     
     Submitted
162. Heath CH, Slavin MA, Handke R, Sorrell TC, Meyer M, Phillips M, Ellis D, Harun A, Nguyen Q, Chen SCA and the Australian Scedosporium (AUSCEDO) Study Group.
     
     Scedosporiosis in Australia: clinical associations and emergence of Scedosporium aurantiacum
     
     Submitted
163. Brown GV, Sorrell TC.
     
     Clinical research in crisis – setting the stage.
     
     Submitted to MJA Jul 08.

Invited Papers and Conference Proceedings

1. Sorrell TC, Munro R.
   
   Methicillin-gentamicin Resistant Staphylococcus aureus: Clinical Aspects and Experience with Vancomycin. In "Second International Symposium on Infections in the Immunocompromised Host" Eds C.S.F. Easmon and H. Gaya.
   
   Academic Press, London, 1983, pp302-305.
2. Munro R, Sorrell TC.
   
   Biliary sepsis - A review of treatment options.
   
   Curr Therap. 27: 39-46, 1986.
3. Lawrence R, Sorrell TC.
   
   Antifungal therapy in the hospital setting.
   
   Hosp Therapeutics, 16-26, August, 1987.
4. Sorrell TC.
   
   Women and AIDS.
   
   Patient Management. June 1989: 77-82.
5. Rawlinson WR, Sorrell TC.
   
   Herpes Zoster: a continuing challenge.
   
   Curr Therap. Oct, 1990, 85-6.
6. Mitchell DH, Sorrell TC, McDonald PJ.
   
   Managing HIV. HIV infection control in medical practice.
   
   Med J Aust, 1995.
7. Sorrell TC, Ellis DH.
   
   Ecology of Cryptococcus neoformans. Editorial.
   
   Editorial Revista Ibero Americana de Microbiologia, 1997;14: 42-43.
8. Himmelreich U, Sorrell TC.
   
   In vivo MRS of patients with infective brain lesions.
   
   In: Proc. 12th World Congress of Neurosurgery. G McCullogh and P Reilly Eds. Openbook Publisher, Adelaide, Australia, 2001 p 98-100.
9. Himmelreich U, Sorrell T, Dzendrowskyj T, Malik R, Mountford C.
   
   Identification of Cryptococcus neoformans by Magnetic Resonance Spectroscopy.
   
   Microbiol Aust. 2002, 23:837-49.
10. Himmelreich U, Mountford CE, Sorrell TC.
    
    NMR spectroscopic determination of microbiological profiles in infectious diseases.
    
    Trends in Applied Spectroscopy (2004) 5:270-283 (Invited review article).
11. Chen SCA, Sorrell TC.
    
    Antifungal Agents
    
    Med J Aust 2007, 187:404-409.
12. Playford EG, Sorrell TC.
    
    Optimising therapy for Candida infections.
    
    Semin Respir Crit Care Med. 28 (6): 678-88, 2007
13. Ellis D, Chen S, Sorrell T.
    
    Impact of antifungal resistance in Australia.
    
    Microbiol Aust. Suppl Nov 2007 p 171-5, 2007.
14. Sorrell TC, Himmelreich U.
    
    NMR in Mycology. Current Fungal Infection Reports
    
    In press Aug 2008
15. Sorrell TC
    
    Editorial.
    
    Current Opinion in Infectious Diseases Nov 2008

Book Chapters

1. T.T. Yoshikawa, A.W., Chow and L.B. Guze, Eds.
   
   "Infectious Diseases Diagnosis and Management".
   

   • Sorrell TC.
     
     Skin Tests.
     
     Chapter 4.
   • Sorrell TC, Ota JK.
     
     Septic Thrombophlebitis & Mycotic Aneurysms.
     
     Chapter.26.
   • Pitchon HE, Sorrell TC.
     
     Infections in the Immunocompromised Host.
     
     Chapter. 27.
   • Sorrell TC, Tillman DB.
     
     Yersiniosis and Plague.
     
     Chapter 42.
   • Sorrell TC.
     
     Enterovirus Infections.
     
     Chapter 65.
   • Sorrell TC.
     
     Viral Diseases Associated with Cutaneous Manifestations.
     
     Chapter 68.
   • Sorrell TC.
     
     Acute Viral Hepatitis.
     
     Chapter 69.
   • Sorrell TC.
     
     Rabies.
     
     Chapter 72.
   • Sorrell TC.
     
     Cat-scratch Disease.
     
     Chapter 75.
   • Sorrell TC.
     
     Gastrointestinal Infections and Infestations.
     
     -
   Houghton-Mifflin Prof. Publ., Medical Division, Boston, 1980.
2. Sorrell TC.
   
   Gastrointestinal and Hepatic Diseases.
   
   Chapter XIX, Section II.. In "Drug Treatment" Ed. T.M. Speight. Third Edition. ADIS Press Ltd., Auckland, N.Z., 1987.
3. Sorrell TC.
   
   Perinatal Infections.
   
   Chapter 21 in "Maternal and Perinatal Care in New South Wales." 3rd Ed. NSW Department of Health, 1989.
4. Sorrell TC.
   
   Fungal Infections.
   
   Chapter 21. In "Natural Immunity" Ed. D.S. Nelson, Academic Press, London 1989.
5. Sorrell TC.
   
   Acute Enteritis and Enterocolitis.
   
   Chapter VII in "Fundamentals of Gastroenterology". Eds L.W. Powell and D.W. Piper. Fourth edition. ADIS Health Scientific Press, Sydney, 1991.
6. Sorrell TC, Gilbert GL.
   
   Infections.
   
   Chapter 17 in "Drug Therapy in Neurology". Ed. M.J. Eadie, Churchill-Livingstone Press, London, 1992.
7. Allen R, Sorrell TC.
   
   The Immunocompromised Surgical Patient.
   
   Chapter 8 in "Current Surgical Practice", Vol 6. Eds M Hobsley, AG Johnson, T Treasure. Edward Arnold, London, 1993.
8. Kesson AM, Sorrell TC.
   
   Human Immunodeficiency Virus Infection in Pregnancy.
   
   Chapter 3 In: Balliere's Clinical Obstetrics and Gynaecology. International Practice and Research. Volume 7 No. 1. Infectious Diseases: Challenges for the 1990s. Ed. Gilbert, G.L. Baillière Tindall, London, 1993.
9. Berenger S, Sorrell TC.
   
   Infection control guidelines - AIDS and related conditions.
   
   Chapter in "The AIDS Manual", Ed. R Penny et al. Third Edition, 1994. NSW Govt. Printing Office.
10. Sorrell TC, Kesson AM.
    
    Issues for the HIV-infected woman.
    
    In: Management of the HIV-infected Patient. Eds. S.M. Crowe, J. Mills, J. Hoy. Cambridge University Press, 1996.
11. Sorrell TC, Gilbert GL.
    
    The Case Study - An example based on the control of Disease due to Haemophilus Influenzae type B
    
    Chapter in "Handbook of Public Health Methods" Eds C Kerr, R Taylor, G Heard. McGraw-Hill Book Company Pty Ltd, 1998.
12. Sorrell TC, Iredell JI, Mitchell DM.
    
    Nocardia species.
    
    Ch. 244 In Mandell’s Principles and Practice of Infectious Diseases, Eds GL Mandell, JE Bennett, R Dolin, Fifth Edition, 2000, pp2637-45.
13. Sorrell TC, Mitchell DM, Iredell JI.
    
    Nocardia species.
    
    Ch 244 In Mandell’s Principles and Practice of Infectious Diseases, Eds GL Mandell, JE Bennett, R Dolin, Sixth Edition, 2005.
14. Yung A, McDonald M, Spelman D, Street A, Johnson P, Sorrell T, McCormack J Eds.
    
    Infectious Diseases – A Clinical Approach.
    

    • Yung A. Stanley P & Sorrell TC.
      
      Prolonged fever and pyrexia of unknown origin
      
      Ch 8.
    • Iredell J & Sorrell TC.
      
      Septicemia
      
      Ch 16.
    • Jones P & Sorrell TC.
      
      Infections in the immunocompromised
      
      Ch 35.
    2nd Edition. IP Communications, Melbourne. ISBN:0-9578617-7-X, 2005.
15. Baumgartner R, Ho TK, Somorjai R, Himmelreich U, Sorrell TC.
    
    Complexity of magnetic resonance spectrum classification.
    
    (7 pages). Chapter in: Data Complexity in Pattern Recognition, Springer Verlag, 2005.
16. Carter EA, Marshal CP, Ali MHM, Ganendren R, Sorrell TC, Wright LC, Lay PA.
    
    Infrared spectroscopy of micro-organisms. Characterisation, Identification and Differentiation.
    
    In: ACS Symposium Book on "New Approaches in Biomedical Spectroscopy" Eds: Katrin Kneipp, Ricardo Aroca, Harald Kneipp, Edeline Wentrup-Byrne. Publ. American Chemical Society, Washington DC 2007, p64-84.
17. Sorrell TC.
    
    Detection of fungal metabolites.
    
    Ch 5 In: Maertens J and Marr K, Eds. Diagnosis of Fungal Infections. CG Egerton Publ. 2007.
18. Chen SCA, Sorrell TC.
    
    Investigational antifungal agents.
    
    Ch In: Kucer’s Use of Antibiotics. Eds Grayson et al, 6th Edn 2008. Under Editorial review
19. Sorrell TC, Chen SCA.
    
    Fungal Immunomodulatory Molecules. In Pathogen-derived Immunomodulatory molecules.
    
    Ed. Fallon P. Publ. Landes Bioscience, Austin, Texas. 13 pages In press (proofs returned 2/7/08).
20. Eds Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A. ASM
    
    Cryptococcus: from human pathogen to model yeast.
    

    • Fox D, Djordjevic J, Sorrell TC.
      
      Signalling cascades and enzymes as virulence factors
      
      -
    • Perfect J, Dromer F, Sorrell TC, Casadevall A.
      
      Latency and Disease
      
      -
    • Sorrell TC, Chen SCA.
      
      Clinical perspective on issues that distinguish management of C. neoformans and C. gattii.
      
      -
    Press. For Publication 2009.

TOI

1. Toi CS, Dwyer DE.
   
   Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.
   
   J Clin Virol. 2008; 43:18-24.
2. Vonlaufen A, Joshi S, Qu Changfa, Phillips PA, Xu Z, Parker NR, Toi CS, Pirola RC, Wilson JS, Goldstein D, Apte MV.
   
   Pancreatic stellate cells: Partners in crime with pancreatic cancer cells.
   
   Cancer Research. 2008; 68: 2085-2093.
3. Frenchen JE, Imazato S, Toi C, Mulder J, Mickenautsch S, Takahashi Y, Ebisu S.
   
   Antibacterial effect of chlorhexidine containing glass-ionomer cement in vivo: a pilot study.
   
   Caries Res 2007; 41(2): 102-107.
4. Toi CS, Cleaton-Jones PE.
   
   The effect of traditional African food mixtures on growth, pH and extracellular polysaccharide production by mutans streptococci in vitro.
   
   Anaerobe 2006; 12: 99-105.
5. Toi CS.
   
   Pathogenesis of dental caries in South African children: a molecular approach.
   
   SA J Epidemiol Infect. 2005; 20 (4): 121-126.
6. Toi CS, Cleaton-Jones P, Fatti P.
   
   Characterization of Streptococcus mutans diversity by determining restriction fragment-length polymorphisms of the gtfB gene of isolates from 5-year-old children and their mothers.
   
   Antonie van Leeuwenhoek 2005; 88: 75-85.
7. Harkison BN, Toi C, Grossman ES, Cleaton-Jones PE, Parak R.
   
   Does mechanical pressure force bacteria into the dentinal tubules of carious and non-carious teeth – an exploratory study.
   
   SADJ 2005; 60: 146-150.
8. Toi C, Cleaton-Jones P.
   
   In vitro growth and acid production by mutans streptococci on traditional African staple foods.
   
   Anaerobe 2004; 10: 335-342.

WANG

1. Wang Q, Kong F, Jelfs P, Gilbert GL.
   
   Extended phage locus typing of Salmonella Typhimurium, using a multiplex PCR/reverse line blot hybridization.
   
   Journal of Medical Microbiology 2008 57:827-38.
2. Wang Q, Chiew R, Howard P, Gilbert GL.
   
   Salmonella Typing in New South Wales: Current methods and application of improved epidemiological tools.
   
   NSW Public Health Bulletin 2008 19(1–2):24-8.
3. Wang Q, Riley TV.
   
   Erysipelothrix rhusiopathiae: forgotten but not gone.
   
   Culture 2008 29(3):5-8.
4. Gallego B., Sintchenko V., Wang Q., Hiley L., Gilbert GL., Coiera E.
   
   Biosurveillance of emerging biothreats using scalable genotype clustering.
   
   Journal of Biomedical Informatics (in press).
5. Munnoch SA, Ward K, Sheridan S, Fitzsimmongs GJ, Shadbolt CT, Piispanen JP, Wang Q, Ward TJ, Worgan TLM, Oxenford C, Musto JA, McAnulty J, Durrheim DN.
   
   A multi-state outbreak of Salmonella Saintpaul in Australia associated with cantaloupe consumption.
   
   Epidemiology & Infection 2008 18:1-8.
6. Cai Y, Kong F, Wang Q, Tong Z, Sintchenko V, Zeng X, Gilbert GL.
   
   Comparison of single- and multilocus sequence typing and toxin gene profiling for characterization of methicillin-resistant Staphylococcus aureus.
   
   Journal of Clinical Microbiology 2007 45(10):3302-8.
7. Wang Q, Chang BJ, Mee BJ, Riley TV.
   
   Neuraminidase production by Erysipelothrix rhusiopathiae.
   
   Veterinary Microbiology 2005 107(3-4):265-72.
8. Wang Q, Fidalgo S, Chang BJ, Mee BJ, Riley TV.
   
   The detection and recovery of Erysipelothrix spp. in meat and abattoir samples in Western Australia
   
   Journal of Applied Microbiology 2002 92:844-50.